WO2014168302A1 - D-psicose epimerase, and psicose production method using same - Google Patents

D-psicose epimerase, and psicose production method using same Download PDF

Info

Publication number
WO2014168302A1
WO2014168302A1 PCT/KR2013/008585 KR2013008585W WO2014168302A1 WO 2014168302 A1 WO2014168302 A1 WO 2014168302A1 KR 2013008585 W KR2013008585 W KR 2013008585W WO 2014168302 A1 WO2014168302 A1 WO 2014168302A1
Authority
WO
WIPO (PCT)
Prior art keywords
fructose
enzyme
protein
epimerase
recombinant strain
Prior art date
Application number
PCT/KR2013/008585
Other languages
French (fr)
Korean (ko)
Inventor
김민정
최정윤
허진솔
김혜정
박종진
이강표
Original Assignee
주식회사 삼양제넥스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 삼양제넥스 filed Critical 주식회사 삼양제넥스
Publication of WO2014168302A1 publication Critical patent/WO2014168302A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90Isomerases (5.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/02Monosaccharides

Definitions

  • the present invention relates to a cosmos 3-epimerase enzyme, a composition for producing a cosmos comprising the enzyme, and a method for producing a cosmos by the enzyme.
  • Psicose is the third carbon epimer of fructose (D-fructose), which is comparable in intensity (70%) and type of sweetness compared to fructose.
  • D-fructose fructose
  • Glucose is the third carbon epimer of fructose (D-fructose), which is comparable in intensity (70%) and type of sweetness compared to fructose.
  • D-fructose is the third carbon epimer of fructose (D-fructose), which is comparable in intensity (70%) and type of sweetness compared to fructose.
  • D-fructose the third carbon epimer of fructose
  • a diet low calorie sweetener because it is hardly metabolized when absorbed into the body.
  • Psychos has a function of inhibiting blood glucose in the body, so it can be used for foods for diabetics or food and drink for receiving diabetics. It can be used for functional foods.
  • One embodiment of the present invention provides a protein having an amino acid sequence of SEQ ID NO: 1 and having an enzymatic activity for converting fructose into a psychose.
  • Another example provides a polynucleotide encoding the protein.
  • Another example provides a recombinant vector comprising a polynucleotide encoding the protein.
  • Another example provides a recombinant strain comprising said recombinant vector.
  • Another iii provides a composition for producing a psychos for producing a psychos from fructose comprising the protein having the amino acid sequence of SEQ ID NO: 1 and at least one selected from the group consisting of the recombinant strain.
  • composition for preparing the psychos provides a method of producing cycos from fructose by reacting with fructose.
  • 1 is a cleavage map of a recombinant vector for expressing the D—Cycos 3-epimerase protein of one embodiment. .
  • FIG. 2 is a graph showing the activity of the D-psicose 3-epimerase of one embodiment according to the added metal group.
  • Figure 3 is a graph showing the activity according to the temperature of the D- psychocos 3-epimerase in one embodiment.
  • ⁇ '' Figure 4 is a graph showing the pH-dependent activity of the D- psychocos 3-epimerase of one embodiment.
  • FIG. 5 is a graph showing the pH-dependent activity of D-psicose 3 ′ epimerase in one example in PIPES buffer.
  • FIG. 6 is a graph showing the time-dependent activity of the acecos 3-epimerase of an example at 50 ° C.
  • FIG. 7 is a graph showing the efficiency of psychos production (cycose conversion) from high fructose fructose using the acecos 3-epimerase of one embodiment.
  • FIG. 8 is a graph showing the results obtained by HPLC measuring psychocosylated productivity from high fructose using a cycos 3-epimerase of one embodiment.
  • FIG. 9 is a graph showing the efficiency of psychos production (cycose conversion) from high fructose using a recombinant strain containing D-psicose 3 ′ epimerase of one embodiment.
  • the inventors of the present invention are non-pathogenic Crosstridium, Luminococos, Treponema, Paracocos, Citrusella. And a study of polynucleotides whose functions are not known among the genetic information of microorganisms included in cynorizobium, Agrobacterium tumefaciens or Rhodobacter spheroides-derived ketose 3-epimerase Catalytic residues are identical and the total amino acid sequence is 40-60% Homologous ketose enzymes were screened.
  • the present invention was completed by synthesizing a polynucleotide sequence optimized for efficient expression of proteins, inserting it into a recombinant vector, and expressing it to obtain an enzyme having an activity of producing ' cos.
  • the present invention confirms that a protein whose function is not known in the prior art has D-psychcos 3 epimerase activity and can be prepared in a high yield : acosicose 3-epimerase of the protein. It is to provide a use as.
  • the present invention will be described in more detail.
  • a protein derived from the crosstridium synth Clostridkm ⁇ , and having a activity of producing cycos from fructose is provided. .
  • the protein may have an amino acid sequence of SEQ ID NO: 1 and have activity to produce sacos from fructose.
  • the protein is epitaxial at the third carbon position of fructose in the process of screening for an enzyme having an activity of producing a psychosis from fructose. It was confirmed that the mercury reaction caused the activity to switch the cycle between fructose.
  • the protein may be an enzyme protein (eg, D-psicose 3-epimerase) that has the activity of producing a psychos from fructose by epimerizing the carbon position 3 of fructose. .
  • the protein may be one having an amino acid sequence of SEQ ID NO: 1, but is not limited thereto, and converts fructose into a psychos as described above. As long as activity is maintained, some of the amino acids of SEQ ID NO: 1 may have been substituted, inserted and / or deleted. for example.
  • the protein may include an amino acid sequence having at least 70%, at least 80%, at least 90%, at least 95%, or at least 99% homology with the amino acid sequence of SEQ ID NO: 1. .
  • the protein may be one having a molecular weight of 30 to 37 kDa, such as 30 to 35 kDa, measured by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS—PAGE).
  • the optimal silver of the protein may be 40 to 65 ° C, specifically 50 to 65 ° C (see Figure 3).
  • the optimum degree of silver may be, for example, a result of progress of the reaction for 5 minutes in the presence of pH 7.0, ImM Co 2+ , but is not limited thereto.
  • the optimal pH of the protein is pH 6 to 9, pH 7 to 9. pH 7 to 8.5. Or pH 7-8 (see FIGS. 4 and 5).
  • the optimum pH may be, for example, a result of progress of the reaction for 5 minutes in the presence of 60 ° C., ImM Co 2+ , but is not limited thereto.
  • the enzyme protein having the amino acid sequence of SEQ ID NO: 1 may have the following properties:
  • Another example of the present invention provides a polynucleotide encoding a protein having the amino acid sequence of Singe SEQ ID NO: 1.
  • Another example provides a recombinant vector comprising a polynucleotide encoding the protein.
  • Another example provides a recombinant strain transformed with a recombinant vector expressing the protein.
  • the polynucleotide encoding the enzyme protein for example, with respect to the base sequence of SEQ ID NO: 2 or SEQ ID NO: 3, or the base sequence It may be one having a sequence having substantial identity.
  • Said substantial identity is such that the nucleotide sequence of SEQ ID NO: 1 or SEQ ID NO: 2 is aligned with any other sequence as much as possible, and the sequence is analyzed to determine that the other sequence is the nucleotide sequence of SEQ ID NO: 2 or SEQ ID NO: 3 And more than 70%, more than 90%. Or 98% or more sequence homology.
  • the polynucleotide is itself. Or in the form of a recombinant vector comprising the polynucleotide.
  • the recombinant vector refers to a recombinant nucleic acid molecule capable of delivering an operably linked target polynucleotide, wherein the target polyline nucleotide is a promoter. And one or more transcriptional regulatory elements consisting of a transcription terminator column.
  • the polynucleotides are, for 'example, chemical inducible element (inducible element) and the temperature. It may be operatively connected with a temperature sensitive element or the like.
  • the chemical inducible element may be selected from the group consisting of lac operon, T7 promoter, trc promoter and the like.
  • the T7 promoter is derived from the virus T7 phage and includes a promoter and a T7 terminator.
  • the recombinant vectors can be constructed as a vector for expression or for cloning vectors (Francois Baneyx, current Opinion Biotechnology 1999, 10: 411-421).
  • the recombinant vector may be used as long as the vector has been used for gene recombination, for example.
  • the recombinant vector may be prepared from one selected from the group consisting of " pET. PBR, pTrc, pLex. PUC vector suitable for expression in E. coli. "
  • the host cell capable of transforming with the recombinant vector may be selected from all microorganisms having an expression system capable of expressing (overexpressing) the enzyme protein, for example, E. coli.
  • RR1, DH5a or W3110 and the like can be exemplified, for example, BL2KDE3) strain can be used, but is not limited thereto.
  • Bacillus subtilis Bacillus strains such as Bacillus thuringiensis, Corynebacteria strains such as Corynebacterium glutamicum, Salmonella strains such as Salmonella typhimurium, Other Ceratia Strains selected from the group consisting of enterobacteria and strains such as Marsesons and various Pseudomonas species may be used.
  • the method of transforming the host cell with the recombinant vector can be selected and used without particular limitation for all transformation methods known in the art, such as fusion of bacterial protoplasts, electroporation, projectile bombardment, and viruses. It may be selected such as an infection using a bag.
  • the recombinant strain may be Escherichia co //-pETCDPE-SYG32 Accession No .: KCCM11406P).
  • the protein having the amino acid sequence of SEQ ID NO: 1 is an enzyme having excellent psychocosylation ability to convert fructose to psychocos Protein. therefore .
  • the protein having the amino acid sequence of SEQ ID NO: 1 or a recombinant strain expressing the same may be usefully used for the preparation of a psychos.
  • a protein having the amino acid sequence of SEQ ID NO: 1 a recombinant strain expressing the protein. Culture of said recombinant strain. And lysates of the recombinant strain .
  • a composition for producing a psychosis comprising at least one selected from the group.
  • the composition for producing a psychos may be to prepare a psychos from fructose using fructose as a substrate.
  • the culture includes an enzyme protein produced from the recombinant strain, and may be in a cell-free form including the recombinant strain or without the strain.
  • the lysate refers to a lysate obtained by crushing the recombinant strain or a supernatant obtained by centrifuging the lysate. It includes an enzyme protein produced from the recombinant strain.
  • the recombinant strain used for the preparation of the psychic means .1 or more species selected from the group consisting of the cells of the strain, the culture of the strain and the lysate of the strain. Used.
  • Another example is a protein having an amino acid sequence of SEQ ID NO: 1, recombinant strain expressing the protein.
  • a method for producing a psychos using the culture of the recombinant strain and at least one selected from the group consisting of lysates of the recombinant strain (hereinafter, 'enzyme protein and the like').
  • Sai ' course production method includes the step of reacting the enzyme protein and the like with fructose.
  • the step of reacting the enzyme protein and the like with fructose may be performed by contacting the elevated protein with fructose.
  • contacting the enzyme protein with fructose may be performed, for example, by mixing the enzyme protein with fructose or contacting fructose with a carrier to which the enzyme protein or the like is immobilized. have.
  • the step of reacting the enzyme protein with fructose comprises culturing the cells of the recombinant strain in a culture medium containing fructose. Can be performed by a step. As such, by reacting the enzyme protein and the like with fructose, the fructose can be converted into the psychos to produce the psychos from the fructose. .
  • the amount of enzyme protein used is 0.001 mg / ml to 1.0 mg / ml, 0.005 mg / ml to l.Omg / ml, 0.01 mg / ml to l.Omg / ml, 0.01 mg / ml to 0.1 mg / ml, or 0.05 mg / ml to aimg / ml. If the amount of the enzyme is lower than the concentration, the cycle conversion efficiency may be lowered. If the concentration is higher than the concentration, the economic range in the industry is lowered, so the range is appropriate.
  • the concentration of fructose used as a substrate is 40 to 75% (w / v), for example, 50 to 75% (w / v), based on the total reaction water, Can be. If the concentration of fructose is lower than the above range, the economy becomes low, and if it is above the above range, fructose does not dissolve well.
  • the concentration of fructose is preferably in the above range.
  • the fructose can be used in the form of a solution dissolved in buffer or water (such as distilled water).
  • the reaction is a condition of pH 6-9, pH 6.8-9.0, pH 7-9, pH 6.8-8.5, pH 7-8.5, pH 6.8-8.0, or pH 7-8 It can be performed under. Also,.
  • the reaction may be carried out at 30 ° C subphase, for example under temperature conditions of 40 ° C or more. If the temperature exceeds 80 ° C browning of fructose as a substrate may occur, the reaction is 30 to 80 ° C, 40 to 75 ° C, 30 to 70 ° C, 40 to 65 ° C, or 50 to 65 ° C It can be carried out under the conditions of.
  • the enzyme concentration in general, the longer the half-unggan interval, the higher the cycle change.
  • the reaction time may be at least 1 hour, such as at least 2 hours, at least 3 hours, at least 4 hours, at least 5 hours, or at least 6 hours. Good to do. 'If the reaction time exceeds 8 hours, As the rate of increase is small or rather declining. The reaction time should not exceed 8 hours. Therefore, the reaction time is 1 to 8 hours. 1 to 6 hours, 1 to 4 hours, 1 to 2 hours, 2 to 8 hours. Or 2 to 6 hours.
  • the above conditions were selected as conditions under which fructose-to-sycos conversion efficiency is maximized.
  • the cell concentration of the strain used is 0.1 mg (dcw: dry cell weight) / ml or more, for example, 0.1 to IGOmgWcw Vml, 0.1 based on the total reaction product.
  • dcw dry cell weight
  • the enzymatic protein having the cyclase converting enzyme activity may be one having a metalloenzyme property in which activation is controlled by metal ions.
  • the metal ions that may contribute to the sacos production yield may be at least one selected from the group consisting of copper ions, manganese ions, calcium silver, magnesium silver, zinc silver, nickel silver, cobalt ions, iron silver, aluminum ions, and the like. It may be at least one selected from the group consisting of manganese ions, iron ions, and cobalt silver.
  • the amount of the metal ion added may be at least O.lmM.
  • the amount of the metal ion exceeds 5mM because the effect is insignificant compared to the excess amount, the amount of the metal ions can "be less than 5mM.
  • the amount of the metal ions to 5mM O.lmM For example, 0.1 to 2 mM, or 0.5 mM to 1.5 mM.
  • the composition for preparing the psychos may further include the above-described metal ions, and the type and content of the metal ions are as described above.
  • the method of producing a psychos may further include the step of adding metal silver and the type and content of metal ions are as described above.
  • the metal ion may be added to the fructose as a substrate, or may be added to a mixture of the enzyme protein and the fructose.
  • the metal ion is added to the carrier to which the enzyme protein or the like is immobilized (before fructose addition).
  • the enzyme protein or the like may be added to the mixture of the immobilized carrier and fructose (after fructose addition), or may be added in the form of fructose and the combination at the time of fructose addition, or respectively.
  • the metal ion may be added to the culture or cultured in a culture medium to which the metal ion is added.
  • the carrier may create an environment in which the activity of the immobilized enzyme protein can be maintained for a long time, and may be any known carrier that can be used for enzyme immobilization.
  • sodium alginate may be used as the carrier.
  • Sodium alginate is a natural colloidal polysaccharide that is abundant in algae cell walls. It contains mannuronic acid ( ⁇ - mannuronic acid) and gluronic acid ( ⁇ —b-gluronic ackl), which are randomly selected. It is formed by forming a -1,4 bond, it may be advantageous to stably fix the strain or enzyme to show a good psychocos yield.
  • a sodium alginate solution e.g. aqueous sodium alginate solution
  • concentration of 1.5 to 4.0% (w / v) such as sodium alginate at a concentration of about 2.5%
  • the solution can be used for immobilization of the strain.
  • the method for producing the psychocos, the Pseudomonas 3 'epimerase protein having an amino acid sequence of SEQ ID NO: 1, or an amino acid sequence of at least 70% homology with the amino acid sequence of SEQ ID NO: 1 may include the step of reacting with fructose.
  • Said psychos production method Adding and / or purifying the Pseudo-3 epimerase enzyme protein having an amino acid sequence of SEQ ID NO: 1 or an amino acid sequence of at least 70% homology with the amino acid sequence of SEQ ID NO: 1 before the reaction step It can be included as. '
  • the method of producing the psycos may include the step of reacting with a fructose a recombinant strain expressing a protein having an amino acid sequence of SEQ ID NO: 1 or an enzyme protein isolated from the system combination strain with fructose.
  • the psicose production method may include the further step of culturing, and recovering the recombinant strain expressing a protein of amino acid sequence of SEQ ID NO: 1 in the previous step the banum.
  • the culturing step of the recombinant strain may be performed under medium and culture conditions which are easily selected by those skilled in the art according to the characteristics of the strain (host cell) used.
  • the culture may be continuous, semi-continuous, or batch culture, but is not limited to these methods.
  • the medium may be any host cell, including E. coli, and any cell that may contain or contain cell contents. Culture media, solutions , solids, semisolids or rigid supports;
  • It may be selected from the group consisting of 2YT medium, LB medium, SOB medium, TB medium and the like.
  • Such recombinant strains and cultures can generally be obtained using conditions suitable for culturing host cells (eg, E. coli).
  • the recombinant strain may be cultured by shaking culture under conditions of 35 ° C to 37 ° C and 150 to 250 rpm.
  • an inducer commonly used in the art may be added to induce overexpression of the enzyme protein.
  • the inducing element is a lac operon or trc promoter, it may be Lactose or IPTG (isopropyl ⁇ -Dl-thiogalactopiopyranoside), and the induction period may be an appropriate time of culture by a person skilled in the art. Can be done on.
  • the recombinant strain may be obtained by performing centrifugation and / or filtration of the obtained culture, and further, fractionating the supernatant or the supernatant obtained by homogenizing and centrifuging the obtained strain. Purification by chromatography can be used to obtain enzyme proteins. For example, a suspension of the recovered strains in 50mM phosphate buffer and then homogenized and then centrifuged, only the supernatant to recover the 20mM.250mM already enzyme protein at a concentration of dachul after absorption in the '-N.TA nickel column (Qiagen) Can be.
  • the step of reacting with fructose can be carried out under optimal activation conditions of the enzyme protein.
  • the fructose may be used at a concentration of 40 to 75% (w / v), such as 50 to 75% (w / v), based on the total counterungmul.
  • the recovered cells may be washed two or more times with, for example, 0.85% (w / v) NaCl or the like before reacting with fructose.
  • the step of reacting with fructose may be performed by further adding ions of at least one metal selected from the group consisting of manganese and cobalt.
  • the metal ions may be added in the range of O.lmM to 5 mM, such as 0.1 to 2 mM, or 0.5 mM to 1.5 mM. If it is less than the above range, the effect of increasing the activity cannot be sufficiently obtained, and if it exceeds the above range, the effect of increasing the activity obtained compared to the amount used is not preferable.
  • obtained from fructose by the method of the present invention can be purified by conventional methods, and such crystals are well known to those skilled in the art. For example, by one or more methods selected from the group consisting of centrifugation, filtration, crystallization, ion exchange chromatography, and combinations thereof.
  • the novel cosmos gepymerase according to the present invention possesses the activity of producing a psychose by epimerizing the third carbon position of fructose.
  • As an enzyme it is useful for the industrial use for the production of psychos, because it is possible to mass-produce cyclose from fructose in high yield under conditions of excellent thermal stability, long half-life and industrially applicable conditions.
  • the D-psicose 3-epimerase of the present invention and the method of producing a psychos using the same are expected to be usefully used as well as in the functional sugar industry, as well as health food materials, pharmaceuticals and cosmetic materials using the same. [Specific contents to carry out invention]
  • the synthesized polynucleotide was inserted into the same restriction enzyme site of pET21a (Novagen), which is an expression vector using restriction enzymes Ndel and XhoKNEB).
  • Recombinant vector pET21a / Phycose epimerase (pET-CDPE) was prepared.
  • the recombinant vector pET-CDPE prepared above is shown in FIG. 1.
  • E. coli BL21 (DE3) (invitrogen) was transformed with the recombinant vector pET-CDPE prepared above by a heat shock method (Sambrook and Russell: Molecular Cloning.) to prepare a recombinant strain.
  • the overexpression-induced culture was centrifuged in a centrifuge 4000rpm for 20 minutes to recover only the cells.
  • the recovered cells were washed twice with 0.85% (w / v) NaCl and used for the following enzyme purification.
  • the prepared recombinant strain was named Escherichia co //-pETCDPE_SYG321 and deposited on March 29, 2013 with the Korea Microorganism Conservation Center and received accession number KCCM11406P.
  • Example 2 Purification and Characterization of D-Pycos 3-Epimerase
  • Example 1 The cells recovered in Example 1 were suspended in lysis buffer (50 mM Tris_HCl 300 mM NaCl pH8.0, 10 mM imidazol) and then disrupted at 4 ° C. for 20 minutes using an ultrasonic processor (ColpParmer). The lysate was centrifuged at 13,000 rpm for 20 minutes to collect only the supernatant, and then placed in a Ni—NTA column (Ni— NTA Superflow. Qiagen) previously equilibrated with lysis buffer. After application, the buffer solution containing 20 mM imidazol and 250 mM imidazol in 50 mM Tris_HCl 300 mM NaCl pH8.0 was sequentially poured. The 50 mM Tris_HCl 300 mM NaCl pH8.0, 250 mM imidazol by the process of blowing the target protein was isolated and purified.
  • lysis buffer 50 mM Tris_HCl 300 mM NaCl pH8.0, 250 mM
  • the isolated purified protein of interest (50mM buffer for enzyme activity measurement)
  • Tagatose or Pycos 3-epimerase known in the art is known to have metal ion requirements. It was examined whether metal ions also affect the D-psicose epimerase obtained in Example 2-1.
  • the metal silver is CuCl 2 , MnCl 2 , CaCl 2 in the protein (enzyme) purified in Example 2-1.
  • Enzyme activity was measured by treating 1 mM of ZnSO 4 , MgSO 4 , NiSO 4 , or CoCl 2 , respectively.
  • the enzyme activity was measured by measuring 50 mM fructose and 0.3 unit / ml of enzyme in the presence of metal ions at 60 ° C. for 5 minutes in 50 mM PIPES buffer solution (pH7,0). After the reaction was heated for 5 minutes at 100 ° C to stop the enzyme activity.
  • the enzyme activity was defined as lunit by the amount of 50 mM fructose and 50 mM PIPES buffer pH7.0 containing ImM Co 2+ , reacted with the enzyme at 60 ° C. to produce an imol (micromole) cyclase per minute as lunit. .
  • a control group Non
  • a metal ion was not treated.
  • the enzymatic activity was calculated by dividing the amount of psychos produced (mM) by the amount of enzyme used and reaction time, and the amount of psychos was analyzed by HPLC.
  • the HPLC analysis was performed at 8CTC using a 87C (BIO-AD) column, flowing 100% (v / v) of water at a flow rate of 0.6 ml / min into the mobile phase, Refractive Psychoproductivity was analyzed by index detector (Agilent 1260 TID). ⁇
  • Enzyme activity in the case of treating each metal silver measured as described above is shown in FIG. 2 compared to the enzyme activity in the control group. As shown in FIG. 2, the enzyme of Example 2-1 was found to increase in activity by the addition of manganese ions, iron silver and cobalt ions, indicating that the metal ions were required.
  • Example 2-1 In order to confirm the activity according to the pH and temperature change of the enzyme purified in Example 2-1, the enzyme and fructose substrate were reacted at various pH and silver and the enzyme activity was confirmed. At this time, for activity measurement, refer to the method described in Example 2.2. Pi—I 4 to 9 and temperature using 50 mM fructose and enzyme 0.3 unit / ml
  • the reaction took place for 5 minutes in the range of 30-80 ° C., after which the reaction was stopped by heating in lOCrc for 5 minutes.
  • the relative activity of the Y axis in FIG. 3 means a relative value when the best enzyme activity is 100.
  • the enzyme showed a high activity in the range of 40 to 65 ° C, specifically 50 to 65 ° C, it can be seen that the maximum activity at 60 ° C. in particular.
  • Example 2.2 With reference to the method described in Example 2.2, to 60 ° C., Standing, 50mM sodium acetate pH 4-6, to determine their activity according to the pH change. Buffer solution of 50 mM sodium citrate pH 5-7, 50 mM piperazine-N, N'-bis (2-ethanesulfonic acid) pH 7.50 mM Tris-HCl pH 7-9, and 50 mM glycine NaOH pH 9-10 The enzyme activity was measured using each of the results. 4 is shown. . , As confirmed in FIG. 4. The enzyme activity was particularly high in the pH 7.0-9.0 range, pH7.0. In addition, among the complete solution corresponding to PH 7.0
  • Substrate at 50 mM concentration that is, fructose, Psicose, tagatose, mannose.
  • Glucose or xylose was used as a substrate and reacted for 5 minutes under pH 7.5 and 60 ° C. in 50 mM PIPES buffer solution containing 1 mM CoCl 2 and 0.3 unit / ml of the enzyme purified in Example 2-1.
  • the degree of activity for each substrate was measured. Enzyme activity was stopped by heating at 100 ° C for 5 minutes.
  • Example 2-1 the enzyme purified in Example 2-1 showed only specific activity among cyclose and fructose among various substrates, and in particular, the substrate specificity of psychose was about 32% higher than that of fructose. Appeared.
  • Known ketose 3-epimerase enzymes are known for
  • the enzyme of the present invention has a characteristic that only reacts specifically to psychos and fructose, and thus, the enzyme and the substrate specificity are different from those known to the tagatose and the sorbose. 2-5.
  • Example 2-1 In order to confirm the stability of the Pseudomonas 3-epimerase according to the degree of silver change, the enzyme purified in Example 2-1 above was heated for 5 hours at 5C C, and then 50 mM fructose was used as a substrate. The enzyme activity was measured by reacting 1 mM CoCl 2 with a 50 mM PIPES complete solution containing 0.3 unit / ml of enzyme under pH 7.5 and 50 ° C. for 5 minutes. Enzyme activity was stopped by heating at 100 ° C for 5 minutes. The results obtained according to the heat treatment time are shown in FIG. 6. As shown in Figure 6, the enzyme purified in Example 2-1 did not significantly decrease the activity until 9 hours, the half-life is calculated to about 20 hours . It was. It is confirmed that the previously reported psychos 3-epimerase enzymes have a half-life of approximately one hour at 50 ° C., whereas the enzyme of the present invention has excellent thermal stability in the same silver.
  • the catalytic efficiency of fructose of the Pseudomonas 3-epimerase of Example 2-1 was 286.28, which is the highest reported catalytic efficiency among the previously reported Sarcos epimerase. It was found to be about 3.3 times higher than the catalytic efficiency 3 ⁇ 4 85 of the psychic 3 ⁇ epimerase derived from mechasion.
  • the enzyme of the present invention has an advantage in terms of the production rate of psychos because the reaction rate is very fast at temperature H (about 50-60 ° C), which is easy to industrially be expected to have an excellent effect on the industrialization of psychos.
  • Example 3 Psychos Production by D-Pycos 3-Epimerase
  • reaction was performed under the optimization conditions selected in Example 2-3 using the D- cyclose 3-eparmerase purified in Example 2-1.
  • D- cyclase 3-epimerase enzyme purified in Example 2-1 at a concentration of 0.005 to 0.1 mg / ml at a high concentration under the conditions of 50 ° C and 50 mM PIPES H 7.5, and cobalt 1 mM It was reacted with (500 g / L) fructose.
  • the yield of the produced reaction was measured to determine the conversion rate of fructose to psychocos.
  • HPLC was performed by diluting the sample sampled at each time by 25 times, and the yield was calculated by substituting the analyzed area (AREA) value for each standard value. Calculated as 50% * 100 per amount / fructose. After ampouling, the calculations show the analysis of fructose and The total amount is 50%.
  • FIG. 8 represents a refractive index.
  • the HPLC analysis was performed using a 87C (BIO-RAD) column at 80 ° C, flowing 100% (v / v) of water into the mobile phase at a flow rate of 0.6 ml / rain, using a Refractive Index Detector (Agilent 1260 TID). Psychos were detected and analyzed for psychos productivity.
  • Example 1 Using the cells of the recombinant strain recovered in Example 1 was tested for the production of the cycle. The reaction was carried out in the same manner as in 3-1, except that the cells of the recombinant strain recovered in Example 1 were used instead of the enzyme of Example 2-1. More specifically, 50 ° C, 50 mM PIPES pH 7.5 Example recombinant strain of 1 10.9, 5.4 or 2.7 mg (cell dry weight) under conditions of a / mK banung water by volume) and 500 g / L to when each banung "Fructose On the basis of the same method as in Example 3-1 was measured for the yield of the psychos and the conversion of the psychos.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

The present invention relates to psicose 3-epimerase of SEQ ID NO:1, a composition for producing psicose containing the epimerase, and the psicose production method using the epimerase.

Description

【명세세  [Specifications
【발명의 명칭】  [Name of invention]
으사이코스 에피머화 효소. 및 이를 이용하는 사이코스 생산방법 【기술분야】  Cycos Epimerase. And Psycho production method using the same [Technical field]
본 발명은 사이코스 3-에피머화 효소, 상기 효소를 포함하는 사이코스 제조용 조성물, 및 상기 효소에 의한 사이코스 생산 방법에 관한 것이다.  The present invention relates to a cosmos 3-epimerase enzyme, a composition for producing a cosmos comprising the enzyme, and a method for producing a cosmos by the enzyme.
【발명의 배경이 되는 기술】 [Technique to become background of invention]
사이코스 (psicose)는 과당 (D-fructose)의 3번 탄소 에피머로, 과당과 비교할 때 감미의 강도 (70%)와 종류에 있어서 유사한 수준이다. 그러나 사이코스는 과당과 달리 체내 흡수 시 거의 대사되지 않아서 다이어트용 저 칼로리 감미료로서 유용하다. 또한, 사이코스는 체내에서 혈당을 억제하는 기능이 있어 당뇨병 환자용 음식 또는 수신용 음식품 등에 사용할 수 있으며, 간에서 지질합성에 관여하는 효소 활성을 억제는 기능이 있어 복부비만을 감소시킬 수 있으므로 다양한.기능성 식품 등에 사용할 수 있다.  Psicose is the third carbon epimer of fructose (D-fructose), which is comparable in intensity (70%) and type of sweetness compared to fructose. However, unlike fructose, it is useful as a diet low calorie sweetener because it is hardly metabolized when absorbed into the body. In addition, Psychos has a function of inhibiting blood glucose in the body, so it can be used for foods for diabetics or food and drink for receiving diabetics. It can be used for functional foods.
- 이와 같은 이유로 사이코스는 다이어트 감미료로서 각광을 받고 있지만, 자연계에 극히 드물게 존재하는 희소당에 속하기 때.문에. 식품 산업에 적용하기 위해서는 사이코스를 효율적으로 대량 생산하는 기술의 개발이 필요하다. For this reason, Psychos is in the limelight as a diet sweetener, but it belongs to a rare sugar that is extremely rare in nature . On the door. Application to the food industry requires the development of technologies for the efficient mass production of psychoses.
종래의 사이코스 제조 방법은 주로 화학적 합성 과정을 거쳐 제조하는 방법이 대부분이었다. 그러나 이 방법은 당밀 처리과정 또는 포도당 이성화 반웅 과정 중에 사이코스가 매우 소량 존재하고, 비용이 많이 소모되며, 부산물이 발^하는 단점이 있다. 이와 같은 문제점을 해결하기 위하여, 과당을 기질로 하는 효소적 방법에 의한 사아코스 생산 방법이 활발이 연구 되고 있다. 그러나 기존의 효소적 방법에 의하면 사이코스를 생산하는 효소들이 알칼리 조건의 pH 하에서 최적을 나타내는 경우가 많은데, 알칼리 조건 하에서의 반응은 당의 갈변화를 유도하기 때문에 산업화에 적당하지 않았다. 또한 기존의: 효소들은 느린 반웅 속도로 인해 사이코스 수율이 저조하여 제조원가가 상승된다는 문제가 있었다. In the conventional method of producing a psychos, most of the methods are mainly manufactured through a chemical synthesis process. However, this method has the disadvantage of having very small amounts of psychocos, expensive and by-products during molasses or glucose isomerization reactions. In order to solve such a problem, a method of producing sacose by an enzymatic method based on fructose has been actively studied. However, according to the existing enzymatic method, the enzymes producing the psychos are alkaline The pH is often optimal under conditions, but the reaction under alkaline conditions is not suitable for industrialization because it induces browning of sugars. Existing enzymes also suffered from poor reaction rates due to slow reaction rates, leading to higher manufacturing costs.
그러므로 사이코스의 생산 수율, 및 온도, pH 및 반웅 속도 등의 반웅 조건이 산업적으로 적용되기에 적합한 새로운 D-사이코스 3-에피머화 효소 개발이 요구된다. ,  Therefore, there is a need for the development of a new D-psicose 3-epimerase enzyme suitable for industrial application of the reaction yield such as the production yield of Pycos, and the temperature, pH and reaction rate. ,
【발명의 내용】  [Content of invention]
【해결하고자 하는 과제】 ^  【Problem to solve】 ^
본 발명의 일 예는 서열번호 1 의 아미노산 서열을 가지며 과당을 사이코스로 전환시키는 효소 활성을 가지는 단백질을 제공한다.  One embodiment of the present invention provides a protein having an amino acid sequence of SEQ ID NO: 1 and having an enzymatic activity for converting fructose into a psychose.
다른 예는 상기 단백질을 암호화하는 폴리뉴클레오타이드를 제공한다. 다른 예는 상기 단백질을 암호화하는 폴리뉴클레오타이드를 포함하는 재조합 백터를 제공한다.  Another example provides a polynucleotide encoding the protein. Another example provides a recombinant vector comprising a polynucleotide encoding the protein.
다른 예는 상기 재조합 백터를 포함하는 재조합 균주를 제공한다.  Another example provides a recombinant strain comprising said recombinant vector.
다른 뎨는 상기 서열번호 1의 아미노산 서열을 갖는 단백질 및 상기 재조합 균주로 이루어진 군에서 선택된 1종 이상을 포함하는 과당으로부터 사이코스를 제조하는 사이코스 제조용 조성물을 제공한다.  Another iii provides a composition for producing a psychos for producing a psychos from fructose comprising the protein having the amino acid sequence of SEQ ID NO: 1 and at least one selected from the group consisting of the recombinant strain.
다른 예는 상기 사이코스 제조용 조성물을 . 과당과 반응시켜 과당으로부터 사이코스를 생산하는 방법을 제공한다.  Another example is the composition for preparing the psychos. It provides a method of producing cycos from fructose by reacting with fructose.
[도면의 간단한 설명】 [Brief Description of Drawings]
도 1은 일 실시예의 D—사이코스 3-에피머화 효소 단백질을 발현하기 위한 재조합 백터의 개열 지도이다. .  1 is a cleavage map of a recombinant vector for expressing the D—Cycos 3-epimerase protein of one embodiment. .
도 2는 일 실시예의 D-사이코스 3-에피머화 효소의 활성을 첨가된 금속 이은 종류에 따라 보여주는 그래프이다. 도 3은 일 실시예의 D-사이코스 3—에피머화 효소의 온도에 따른 활성을 보여주는 그래프이다. ' ' · 도 4는 일 실시예의 D—사이코스 3-에피머화 효소의 pH에 따른 활성을 보여주는 그래프이다. FIG. 2 is a graph showing the activity of the D-psicose 3-epimerase of one embodiment according to the added metal group. Figure 3 is a graph showing the activity according to the temperature of the D- psychocos 3-epimerase in one embodiment. '' Figure 4 is a graph showing the pH-dependent activity of the D- psychocos 3-epimerase of one embodiment.
도 5는 PIPES 버퍼에서의 일 실시예의 D-사이코스 3ᅳ에피머화 효소의 pH에 따른 활성을 보여주는 그래프이다.  FIG. 5 is a graph showing the pH-dependent activity of D-psicose 3 ′ epimerase in one example in PIPES buffer. FIG.
도 6은 50°C에서의 일 실시예의 으사이코스 3-에피머화 효소의 활성을 시간별로 보여주는 그래프이다ᅳ FIG. 6 is a graph showing the time-dependent activity of the acecos 3-epimerase of an example at 50 ° C. FIG.
도 7은 일 실시예의 으사이코스 3-에피머화 효소를 이용한 고농도 과당으로부터의 사이코스 생산 효율 (사이코스 전환률)을 보여주는 그래프이다. 도 8은 일 실시예의 으사이코스 3-에피머화 효소를 이용한 고농도 과당으로부터의 사이코스 생산성을 HPLC에 의해 측정한 결과를 나타내는 그래프이다.  FIG. 7 is a graph showing the efficiency of psychos production (cycose conversion) from high fructose fructose using the acecos 3-epimerase of one embodiment. FIG. 8 is a graph showing the results obtained by HPLC measuring psychocosylated productivity from high fructose using a cycos 3-epimerase of one embodiment.
도 9는 일 실시예의 D-사이코스 3ᅳ에피머화 효소를 함유하는 재조합 균주를 이용한 고농도 과당으로부터의 사이코스 생산 효율 (사이코스 전환률)을 보여주는 그래프이다.  FIG. 9 is a graph showing the efficiency of psychos production (cycose conversion) from high fructose using a recombinant strain containing D-psicose 3 ′ epimerase of one embodiment.
도 10은 크로스트리디움 sdndens^入\ 유래된
Figure imgf000004_0001
10 is derived from crosstridium sdndens ^ 入 \
Figure imgf000004_0001
단백질의 아미노산 서열 (서열번호 1)을 보여준다. 【과제의 해결 수단】 The amino acid sequence of the protein (SEQ ID NO: 1) is shown. [Measures of problem]
본 발명자들은 비 병원성인 크로스트리디움 속, 루미노코코스 속, 트레포네마 속, 파라코코스 속, 시트레이셀라 속. 및 시노리조비움 속에 포함되는 미생물의 유전정보 중에서 그 기능이 밝혀지지 않은 폴리뉴클레오타이드에 대하여 연구를 거듭하던 중, 아그로박테리움 투메패시엔스 또는 로도박터 스페로이데스 유래 케토오스 3-에피머화 효소와 촉매활성 잔기는 일치하며 전체 아미노산 서열은 40 내지 60% 정도의 상동성이 있는 케토오스 효소를 스크리닝 하였다 . The inventors of the present invention are non-pathogenic Crosstridium, Luminococos, Treponema, Paracocos, Citrusella. And a study of polynucleotides whose functions are not known among the genetic information of microorganisms included in cynorizobium, Agrobacterium tumefaciens or Rhodobacter spheroides-derived ketose 3-epimerase Catalytic residues are identical and the total amino acid sequence is 40-60% Homologous ketose enzymes were screened.
그 결과 크로스트리디움 신댄스가 가지고 있는 전체 유전자 중에서 과당을 사이코스로 전환할 수 있는 효소를 암호화하는 폴리뉴클레오타이드를 최초로 밝힐 수 있었다.  As a result, it was the first to identify a polynucleotide that encodes an enzyme capable of converting fructose into a psychocos among the entire genes of Crosstridium synth.
또한 이에 따라 단백질의 효과적인 발현을 위하여 최적화한 폴리뉴클레오타이드 서열을 합성하고 이를 재조합 백터에 삽입하고 발현시켜 과당으로부터 '사이코스를 생산하는 활성을 갖는 효소를 확보함으로써 본 발명을 완성하게 되었다. In addition, the present invention was completed by synthesizing a polynucleotide sequence optimized for efficient expression of proteins, inserting it into a recombinant vector, and expressing it to obtain an enzyme having an activity of producing ' cos.
즉, 본 발명은 종래에 기능이 밝혀지지 않은 단백질이 D—사이코스 3 에피머화 효소 활성을 가지며 고수율로 사이코스를 제조할 수 있음을 확인하여: 상기 단백질의 으사이코스 3-에피머화 효소로서의 용도를 제공하는 것이다. 이하 본 발명을 보다 상세히 설명하기로 한다. That is, the present invention confirms that a protein whose function is not known in the prior art has D-psychcos 3 epimerase activity and can be prepared in a high yield : acosicose 3-epimerase of the protein. It is to provide a use as. Hereinafter, the present invention will be described in more detail.
우선, 본 발명의 일 예에서, 크로스트리디움 신댄스 Clostridkm ^에서 유래한 것으로, 과당으로부터 사이코스를 생산하는 활성을 가지는 단백질이 제공된다. .  First, in one embodiment of the present invention, a protein derived from the crosstridium synth Clostridkm ^, and having a activity of producing cycos from fructose, is provided. .
예컨대, 상기 단백질은 서열번호 1 의 아미노산 서열을 가지며 과당으로부터 사아코스를 생산하는 활성을 가지는 것일 수 있다.  For example, the protein may have an amino acid sequence of SEQ ID NO: 1 and have activity to produce sacos from fructose.
상기 단백질은 미생물에서 실제 이를 코딩하는 유전자 염기서열 및 생화학적 기능 특성이 알려진바 없으나, 과당으로부터 사이코스를 생산하는 활성을 가지는 효소를 스크리닝 하는 과정에서, 상기 단백질이 과당의 3번째 탄소 위치에서 에피머화 반웅을 일으켜 과당으로부터 사이코스를 전환 할 수 있는 활성을 가짐을 확인하였다. 따라서, 상기 단백질은 과당의 3번 탄소 위치를 에피머화함으로써 과당으로부터 사이코스를 생산하는 활성을 갖는 효소 단백질 (예컨대, D-사이코스 3-에피머화 효소)일 수 있다. . Although the protein sequence and biochemical functional properties of the protein which encodes it are not known in a microorganism, the protein is epitaxial at the third carbon position of fructose in the process of screening for an enzyme having an activity of producing a psychosis from fructose. It was confirmed that the mercury reaction caused the activity to switch the cycle between fructose. Thus, the protein may be an enzyme protein (eg, D-psicose 3-epimerase) that has the activity of producing a psychos from fructose by epimerizing the carbon position 3 of fructose. .
상기 단백질은 서열번호 1의 아미노산 서열을 갖는 것일 수 있으나, 이에 한정되지 않고, 앞서 설명한 바와 같이 과당을 사이코스로 전환하는 활성이 유지되는 한, 서열번호 1의 아미노산 중 일부가 치환, 삽입 및 /또는 결실된 것일 宁 있다. 예컨대. 상기 단백질은 서열번호 1의 아미노산 서열과 70% 이상, 80% 이상, 90% 이상, 95% 이상, 또는 99% 이상의 상동성을 갖는 아미노산 서열을 포함하는 것일 수 있다. . The protein may be one having an amino acid sequence of SEQ ID NO: 1, but is not limited thereto, and converts fructose into a psychos as described above. As long as activity is maintained, some of the amino acids of SEQ ID NO: 1 may have been substituted, inserted and / or deleted. for example. The protein may include an amino acid sequence having at least 70%, at least 80%, at least 90%, at least 95%, or at least 99% homology with the amino acid sequence of SEQ ID NO: 1. .
' 상기 단백질은 소디움 도데실 설페이트 폴리아크릴아미드 젤 전기영동 법 (SDS— PAGE)으로 측정된 단량체의 분자량이 30 내지 37 kDa, 예컨대 30 내지 35 kDa인 것일 수 있다. 상기 단백질의 최적 은도는 40 내지 65°C, 구체적으로 50 내지 65 °C 일 수 있다 (도 3 참조). 상기 최적 은도는, 예컨대, pH 7.0, ImM Co2+ 존재 하에서 5분간 반응 진행 시의 결과일 수 있으나 이에 제한되지는 않는다. 또한 상기 단백질의 최적 pH는 pH 6 내지 9, pH 7 내지 9. pH 7 내지 8.5. 또는 pH 7 내지 8일 수 있다 (도 4 및 도 5 참조). 상기 최적 pH는 예컨대, 60 °C, ImM Co2+ 존재 하에서 5분간 반응 진행의 결과일 수 있으나, 이에 제한되는 것은 아니다. The protein may be one having a molecular weight of 30 to 37 kDa, such as 30 to 35 kDa, measured by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS—PAGE). The optimal silver of the protein may be 40 to 65 ° C, specifically 50 to 65 ° C (see Figure 3). The optimum degree of silver may be, for example, a result of progress of the reaction for 5 minutes in the presence of pH 7.0, ImM Co 2+ , but is not limited thereto. In addition, the optimal pH of the protein is pH 6 to 9, pH 7 to 9. pH 7 to 8.5. Or pH 7-8 (see FIGS. 4 and 5). The optimum pH may be, for example, a result of progress of the reaction for 5 minutes in the presence of 60 ° C., ImM Co 2+ , but is not limited thereto.
상기 서열번호 1의 아미노산 서열을 갖는 효소 단백질은 다음과 같은 특성을 보유하는 것일 수 있다:  The enzyme protein having the amino acid sequence of SEQ ID NO: 1 may have the following properties:
(a) 분자량: 30 내지 37 kDa, 또는 30 내지 35 kDa; .  (a) molecular weight: 30 to 37 kDa, or 30 to 35 kDa; .
(b) 최적 활성 온도: 40 내지 65°C, 또는 50 내지 65°C; 및 (b) optimum active temperature: 40 to 65 ° C., or 50 to 65 ° C .; And
(c) 최적 활성 pH: pH 6 내지 9, H 6.8 내지 9.0, pH 7 내지 9, pH 6.8 내지 8.5, pH 7 내지 8.5, pH 6.8 내지' 8.0, 또는 pH 7 내지 ·8. (c) Activity optimum pH: pH 6 to 9, H 6.8 to 9.0, pH 7 to 9, pH 6.8 to 8.5, pH 7 to 8.5, pH 6.8 to 8.0, or pH 7 to .8.
본 발명의 다른 예는, 싱기 서열번호 1의 아미노산 서열을 갖는 단백질을 암호화하는 폴리뉴클레오타이드를 제공한다. 다른 예는 상기 단백질을 암호화하는 폴리뉴클레오타이드를 포함하는 재조합 백터를 제공한다. 또 다른 예는 상기 단백질을 발현하는 재조합 백터로 형질전환된 재조합 균주를 제공한다.  Another example of the present invention provides a polynucleotide encoding a protein having the amino acid sequence of Singe SEQ ID NO: 1. Another example provides a recombinant vector comprising a polynucleotide encoding the protein. Another example provides a recombinant strain transformed with a recombinant vector expressing the protein.
상기 효소 단백질을 암호화하는 폴리뉴클레오타이드는, 예컨대, 서열번호 2 또는 서열번호 3의 염기 서열, 또는 상기 염기서열에 대하여 실질적 동일성을 갖는 서열을 갖는 것일 수 있다. 상기꾀 실질적인 동일성은 서열번호 1 또는 서열번호 2 의 염기 서열과 임의의 다른 서열을 최대한 대응되도특 정렬하고, 그 서열을 분석하여, 상기 임의의 다른 서열이 서열번호 2 또는 서열번호 3의 염기 서열과 70% 이상, 90% 이상. 또는 98% 이상의 서열 상동성을 갖는 것을 의미한다. The polynucleotide encoding the enzyme protein, for example, with respect to the base sequence of SEQ ID NO: 2 or SEQ ID NO: 3, or the base sequence It may be one having a sequence having substantial identity. Said substantial identity is such that the nucleotide sequence of SEQ ID NO: 1 or SEQ ID NO: 2 is aligned with any other sequence as much as possible, and the sequence is analyzed to determine that the other sequence is the nucleotide sequence of SEQ ID NO: 2 or SEQ ID NO: 3 And more than 70%, more than 90%. Or 98% or more sequence homology.
당해 분야의 통상의 지식을 가진 기술자는 당해 분야에 공지된 유전자 재조합 기술 등을 이용하여 상기 폴리뉴클레오타이드의 염기서열 중 하나 또는 그 이상의 염기를 치환, 부가 또는 결실시킴으로써 상기 실질적 상동성을 갖는 범위에서 동일한 활성을 갖는 효소 단백질을 암호화하는 폴리뉴클레오타이드를 제조할 수 있음을 용이하게 이해할 수 있을 것이다. 이러한 상동성의 비교는 시판되는 컴퓨터 프로그램을 이용하여 2개 이상의 서열간의 상동성을 백분율 (%)로 계산하여 수행될 수 있다.  One of ordinary skill in the art will recognize the same in a range having substantially the same homology by substituting, adding or deleting one or more bases of the nucleotide sequence of the polynucleotide using genetic recombination techniques known in the art. It will be readily appreciated that polynucleotides encoding enzymatic proteins with activity can be prepared. Such homology comparisons can be performed by calculating homology between two or more sequences as a percentage (%) using commercially available computer programs.
상기 폴리뉴클레오타이드는 그 자체로. 또는 상기 폴리뉴클레오타이드를 포함하는 재조합 백터의 형태로 사용될 수 있다. 상기 재조합 백터란 작동 가능하도록 연결된 목적 폴리뉴클레오타이드를 전달할 수 있는 재조합 핵산 분자를 의미하며-ᅳ 상기 목적 폴린뉴클레오타이드는 프로모터. 및 전사 종결인자 둥으로 이루어지는 하나 이상의 전사 조절 요소와 작동 가능하게 연결되어 있는 것일 수 있다. 또한, 상기 폴리뉴클레오타이드는 예를 '들면, 화학물질 유도성 요소 (inducible element) 및 온도 . 민감성 요소 (temperature sensitive element)등과 작동 가능하게 연결된 것일 수 있다. 상기 화학물질 유도성 요소 (inducible element)는 lac 오페론, T7 프로모터, trc 프로모터 등으로 이루어진 군으로부터 선택되는 것일 수 있다. 상기 T7 프로모터는 바이러스인 T7 파지에서 유래된 것으로 프로모터와 함깨 T7 터미네이터를 포함한다. ' 상기 재조합 백터는 당업계에 널리 알려진 방법을 통해 클로닝을 위한 백터 또는 발현을 위한 백터로서 구축될 수 있다 (Francois Baneyx, current Opinion Biotechnology 1999, 10:411-421). 상기 재조합 백터는 유전자 재초합에 이용되어온 백터라면 모두 사용이 무방하며, 예컨대. 플라스미드 발현백터, 바이러스 발현백터 (예, 복제결함 레트로바이러스, 아데노바이러스, 및 아데노 연관 바이러스) 및 이들과 동등한 기능을 수행할 수 있는 바이러스 백터 등으로 이루어진 군에서 선택된 것일 수 있으나, 이들에 한정되는 것은 아니다. 예컨대. 상기 재조합 백터는 대장균 내 발현에 적 "한 pET. pBR, pTrc, pLex. pUC 백터 등으로 이루어진 군에서 선택된 것으로부터 제작된 것일 수 있다. The polynucleotide is itself. Or in the form of a recombinant vector comprising the polynucleotide. The recombinant vector refers to a recombinant nucleic acid molecule capable of delivering an operably linked target polynucleotide, wherein the target polyline nucleotide is a promoter. And one or more transcriptional regulatory elements consisting of a transcription terminator column. Further, the polynucleotides are, for 'example, chemical inducible element (inducible element) and the temperature. It may be operatively connected with a temperature sensitive element or the like. The chemical inducible element may be selected from the group consisting of lac operon, T7 promoter, trc promoter and the like. The T7 promoter is derived from the virus T7 phage and includes a promoter and a T7 terminator. 'Through methods well known in the art, the recombinant vectors can be constructed as a vector for expression or for cloning vectors (Francois Baneyx, current Opinion Biotechnology 1999, 10: 411-421). The recombinant vector may be used as long as the vector has been used for gene recombination, for example. It may be selected from the group consisting of plasmid expression vector, viral expression vector (e.g., replication-defective retrovirus, adenovirus, and adeno-associated virus) and viral vectors capable of performing their equivalent functions, but are not limited thereto. no. for example. The recombinant vector may be prepared from one selected from the group consisting of " pET. PBR, pTrc, pLex. PUC vector suitable for expression in E. coli. "
상기 재조합 백터로 형질전환 시킬 수 있는 숙주 세포는 상기 효소 단백질을 발현 (과발현)시킬 수 있는 발현 시스템을 갖는 모든 미생물중에서 선택된 것일 수 있으며, 예컨대, 대장균일 수 있다. 상기 대장균으로 BL21, JM109. K-12. LE392. RR1, DH5a 또는 W3110 등을 예시할 수 있으며, 예컨대, BL2KDE3) 균주를 사용할 수 있으나, 이에 제한되는 것은 아니다. 이 외에도, 상기 숙주 세포로서 바실러스 서브틸리스, 바실러스 츄린겐시스와 같은 바실러스속 균주, 코리네박테리움 글루타미쿰과 같은 코리네 박테리아속 균주, 살모넬라 티피무리움 등의 살모넬라속 균주, 기타 세라티아 마르세슨스 및 다양한 슈도모나스 종과 같은 장내균과 균주 등으로 이루어진 군에서 선택된 균주를 사용하여도 무방하다..  The host cell capable of transforming with the recombinant vector may be selected from all microorganisms having an expression system capable of expressing (overexpressing) the enzyme protein, for example, E. coli. E. coli BL21, JM109. K-12. LE392. RR1, DH5a or W3110 and the like can be exemplified, for example, BL2KDE3) strain can be used, but is not limited thereto. In addition, as the host cell, Bacillus subtilis, Bacillus strains such as Bacillus thuringiensis, Corynebacteria strains such as Corynebacterium glutamicum, Salmonella strains such as Salmonella typhimurium, Other Ceratia Strains selected from the group consisting of enterobacteria and strains such as Marsesons and various Pseudomonas species may be used.
상기 재조합 백터로 숙주 세포를 형질전환시키는 방법은 당업계에 공지된 모든 형질전환 방법 특별한 제한 없이 선택하여 사용할 수 있으며, 예컨대, 세균 원형질체의 융합, 전기 천공법, 추진체 포격 (projectile bombardment), 및 바이러스 백테를 사용한 감염 등 선택된 것일 수 있다.  The method of transforming the host cell with the recombinant vector can be selected and used without particular limitation for all transformation methods known in the art, such as fusion of bacterial protoplasts, electroporation, projectile bombardment, and viruses. It may be selected such as an infection using a bag.
일 예에서 상기 재조합 균주는 Escherichia co//-pETCDPE- SYG32 기탁번호: KCCM11406P)일 수 있다.  In one example, the recombinant strain may be Escherichia co //-pETCDPE-SYG32 Accession No .: KCCM11406P).
앞서 설명한 바와 같이, 상기 서열번호 1의 아미노산 서열을 갖는 단백질은 과당을 사이코스로 전환시키는 사이코스 전환능이 우수한 효소 단백질이다. 따라서 . 상기 서열번호 1의 아미노산 서열을 갖는 단백질 또는 이를 발현하는 재조합 균주는 사이코스 제조에 유용하게 작용될 수 있다. As described above, the protein having the amino acid sequence of SEQ ID NO: 1 is an enzyme having excellent psychocosylation ability to convert fructose to psychocos Protein. therefore . The protein having the amino acid sequence of SEQ ID NO: 1 or a recombinant strain expressing the same may be usefully used for the preparation of a psychos.
따라서. 본 발명의 다른 예는, 상기 서열번호 1의 아미노산 서열을 갖는 단백질, 상기 단백질을 발현하는 재조합 균주. 상기 재조합 균주의 배양물. 및 상기 재조합 균주의 파쇄물로 이루어진.군에서 선택된 1종 이상을 포함하는, 사이코스 제조용 조성물을 제공한다. 상기 사이코스 제조용 조성물은 과당을 기질로 하여 과당으로부터 사이코스를 제조하는 것일 수 있다. 상기 배양물은 상기 재조합 균주로부터 생산된 효소 단백질을 포함하는 것으로, 상기 재조합 균주를 포함하거나, 균주를 포함하지 않는 cell-free 형태일 수 있다. 상기 파쇄물은 상기 재조합 균주를 파쇄한 파쇄물 또는 상기 파쇄물을 원심분리하여 얻어진 상등액을 의미하는 것으로. 상기 재조합 균주로부터 생산된 효소 단백질을 포함하는 것이다. 본 명세서에 있어서, 별도의 언급이 없는 한, 사이코스의 제조에 사용되는 재조합 균주는 상기 균주의 균체, 상기 균주의 배양물 및 상기 균주의 파쇄물로 이루어진 군에서 선택된 .1종 이상을 의미하는 것으로 사용된다. therefore. Another example of the present invention, a protein having the amino acid sequence of SEQ ID NO: 1, a recombinant strain expressing the protein. Culture of said recombinant strain. And lysates of the recombinant strain . Provided is a composition for producing a psychosis comprising at least one selected from the group. The composition for producing a psychos may be to prepare a psychos from fructose using fructose as a substrate. The culture includes an enzyme protein produced from the recombinant strain, and may be in a cell-free form including the recombinant strain or without the strain. The lysate refers to a lysate obtained by crushing the recombinant strain or a supernatant obtained by centrifuging the lysate. It includes an enzyme protein produced from the recombinant strain. In the present specification, unless otherwise stated, the recombinant strain used for the preparation of the psychic means .1 or more species selected from the group consisting of the cells of the strain, the culture of the strain and the lysate of the strain. Used.
다른 예는 상기 서열번호 1의 아미노산 서열을 갖는 단백질, 상기 단백질을 발현하는 재조합 균주. 상기 재조합 균주의 배양물, 및 상기 재조합 균주의 파쇄물 (이하, '효소 단백질 등')로 이루어진 군에서 선택된 1종 이상을 사용하는 사이코스 생산 방법이 제공된다. 상기 사이'코스 생산 방법은 상기 효소 단백질 등을 과당과 반웅시키는 단계를 포함한다. 일 구체예에서, 상기 효소 단백질 등을 과당과 반웅시키는 단계는 상가단백질을 과당과 접촉시키는 단계에 의하여 수행될 수 있다. 일 구체예에서, 상기 효소 단백질 등을 과당과 접촉시키는 단계는, 예컨대, 상기 효소 단백질 등을 과당과 흔합하는 단계 또는 상기 효소 단백질 등이 고정화된 담 체에 과당을 접촉시키는 단계에 의하여 수행될 수 있다. 또 다른 예에서 상기 효소 단백질 등을 과당과 반웅시키는 단계는 상기 재조합 균주의 균체를 과당이 포함된 배양 배지에서 배양하는 단계에 의하여 수행될 수 있다. 이와 같이 상기 효소 단백질 등을 과당과 반응시킴으로써 과당을 사이코스로 전환하여 과당으로부터 사이코스를 생산할 수 있다. . Another example is a protein having an amino acid sequence of SEQ ID NO: 1, recombinant strain expressing the protein. Provided are a method for producing a psychos using the culture of the recombinant strain and at least one selected from the group consisting of lysates of the recombinant strain (hereinafter, 'enzyme protein and the like'). Sai ' course production method includes the step of reacting the enzyme protein and the like with fructose. In one embodiment, the step of reacting the enzyme protein and the like with fructose may be performed by contacting the elevated protein with fructose. In one embodiment, contacting the enzyme protein with fructose may be performed, for example, by mixing the enzyme protein with fructose or contacting fructose with a carrier to which the enzyme protein or the like is immobilized. have. In another example, the step of reacting the enzyme protein with fructose comprises culturing the cells of the recombinant strain in a culture medium containing fructose. Can be performed by a step. As such, by reacting the enzyme protein and the like with fructose, the fructose can be converted into the psychos to produce the psychos from the fructose. .
상기 사이코스 생산 방법에 있어서, 효율적인 사이코스 생산을 위하여 , 사용되는 효소 단백질의 양은 전체 반웅물 기준으로 0.001 mg/ml 내지 1.0mg/ml, 0.005mg/ml 내지 l.Omg/ml, 0.01 mg/ml 내지 l.Omg/ml, 0.01 mg/ml 내지 0.1 mg/ml, 또는 0.05mg/ml 내지 aimg/ml일 수 있다. 효소의 사용량이 상기 농도보다 낮으면 사이코스 전환 효율이 낮아 질 수 있고, 상기 농도보다 높으면 산업에서의 경제성이 낮아지므로 상기 범위가 적당하다ᅳ  In the above method for producing a psychos, the amount of enzyme protein used is 0.001 mg / ml to 1.0 mg / ml, 0.005 mg / ml to l.Omg / ml, 0.01 mg / ml to l.Omg / ml, 0.01 mg / ml to 0.1 mg / ml, or 0.05 mg / ml to aimg / ml. If the amount of the enzyme is lower than the concentration, the cycle conversion efficiency may be lowered. If the concentration is higher than the concentration, the economic range in the industry is lowered, so the range is appropriate.
상기 사아코스 생산 방법에 있어서, 효율적인 사이코스 생산을 위하여, 기질로서 사용되는 과당의 농도는 전체 반웅물 기준으로 40 내지 75%(w/v), 예컨대, 50 내지 75%(w/v)일 수 있다. 과당의 농도가 상기 범위보다 낮으면 경제성이 낮아지고, 상기 범위보다 높으면 과당이 잘 용해되지 않으므로. 과당의 농도는 상기 범위로 하는 것이 좋다. 상기 과당은 완충용액 또는 물 (예컨대 증류수)에 용해된 용액 상태로 사용될 수 있다.  In the above method for producing sacose, the concentration of fructose used as a substrate is 40 to 75% (w / v), for example, 50 to 75% (w / v), based on the total reaction water, Can be. If the concentration of fructose is lower than the above range, the economy becomes low, and if it is above the above range, fructose does not dissolve well. The concentration of fructose is preferably in the above range. The fructose can be used in the form of a solution dissolved in buffer or water (such as distilled water).
상기 효소 단백질의 최적 조건을 고려할 때, 상기 반웅은 pH 6 내지 9, pH 6.8 내지 9.0, pH 7 내지 9, pH 6.8 내지 8.5, pH 7 내지 8.5, pH 6.8 내지 8.0, 또는 pH 7 내지 8의 조건 하에서 수행될 수 있다. 또한,. 상기 반웅은 30 °C 아상, 예컨대 40°C 이상의 온도 조건 하에서 수행될 수 있다. 온도가 80°C을 넘으면 기질인 과당의 갈변 현상이 일어날 수 있으므로, 상기 반웅은 30 내지 80°C, 40 내지 75 °C, 30 내지 70 Ό, 40 내지 65 °C, 또는 50 내지 65°C의 조건 하에서 수행될 수 있다. 또한, 효소 농도에 따라서 달라지지만, 대체적으로 반웅사간이 길수록 사이코스 전환를이 높아진다. 예컨대, 효소의 열안정성 (예컨대, 50 °C에서의 열안정성)을 고려하여, 상기 반웅 시간은 1시간 이상, 예컨대 2시간 이상, 3시간 이상, 4시간 이상, 5시간 이상 또는 6시간 이상으로 하는 것이 좋다.' 반응시간이 8 시간을 넘어가면 사이코스 전환률의 증가율이 미미하거나 오히려 감소하므로. 반웅시간은 8시간을 넘기지 않는 것이 좋다. 따라서 상기 반웅 시간은 1 내지 8시간. 1 내지 6시간, 1 내지 4시간, 1 내지 2시간, 2 내지 8시간. 또는 2 내지 6시간으로 할 수 있다. 상기 조건은 과당에서 사이코스로의 전환 효율이 최대화되는 조건으로서 선정된 것이다. Considering the optimum conditions of the enzyme protein, the reaction is a condition of pH 6-9, pH 6.8-9.0, pH 7-9, pH 6.8-8.5, pH 7-8.5, pH 6.8-8.0, or pH 7-8 It can be performed under. Also,. The reaction may be carried out at 30 ° C subphase, for example under temperature conditions of 40 ° C or more. If the temperature exceeds 80 ° C browning of fructose as a substrate may occur, the reaction is 30 to 80 ° C, 40 to 75 ° C, 30 to 70 ° C, 40 to 65 ° C, or 50 to 65 ° C It can be carried out under the conditions of. In addition, although it depends on the enzyme concentration, in general, the longer the half-unggan interval, the higher the cycle change. For example, taking into account the thermal stability of the enzyme (eg, thermal stability at 50 ° C.), the reaction time may be at least 1 hour, such as at least 2 hours, at least 3 hours, at least 4 hours, at least 5 hours, or at least 6 hours. Good to do. 'If the reaction time exceeds 8 hours, As the rate of increase is small or rather declining. The reaction time should not exceed 8 hours. Therefore, the reaction time is 1 to 8 hours. 1 to 6 hours, 1 to 4 hours, 1 to 2 hours, 2 to 8 hours. Or 2 to 6 hours. The above conditions were selected as conditions under which fructose-to-sycos conversion efficiency is maximized.
또한, 상기 사이코스 생산 방법에 있어서, 재조합 균주를 사용하는 경우, 사용되는 균주의 균체 농도는 전체 반웅물을 기준으로 0.1 mg(dcw: 건조세포중량 )/ml 이상, 예컨대, 0.1 내지 IGOmgWcwVml, 0.1 내지 50mg(dc )/ml 0.1 내지 10mg(dc\v)/ml, 1 내지 100mg(dcw)/ml,  In addition, in the above method for producing a psychos, when the recombinant strain is used, the cell concentration of the strain used is 0.1 mg (dcw: dry cell weight) / ml or more, for example, 0.1 to IGOmgWcw Vml, 0.1 based on the total reaction product. To 50 mg (dc) / ml 0.1 to 10 mg (dc \ v) / ml, 1 to 100 mg (dcw) / ml,
50mg(dcw)/ml 1 내지 10mg(dcw)/ml, 2 내지 100 mg(dcw)/mlT 50 mg (dcw) / ml 1 to 10 mg (dcw) / ml, 2 to 100 mg (dcw) / ml T
50mg(dcw)/ml 2 내지 10 mg(clcw)/ml. 3 내지 , 100mg(dcw)/ml
Figure imgf000011_0001
50mg(dcw)/ml 또는 내지 3 내지 10mg(dc\v)/ml. 일 수 있다.
50 mg (dcw) / ml 2 to 10 mg (clcw) / ml. 3 to 100 mg (dcw) / ml
Figure imgf000011_0001
50 mg (dcw) / ml or from 3 to 10 mg (dc \ v) / ml . Can be.
상기 사이코스 전환효소 활성을 갖는 효소 단백질은 금속 이온에 의해 활성화가 조절되는 금속효소 (metalloenzyme) 특성을 갖는 것일 수 있다. 상기 효소 단백질에 의한 반응을 금속 이은 존재 하에서 수행함으로써 사이코스의 생산 수율을 증진시킬 수 있다. 사아코스 생산 수율에 기여할 수 있는 금속이온은 구리 이온, 망간 이온, 칼슘 이은, 마그네슘 이은, 아연 이은, 니켈 이은, 코발트 이온, 철 이은, 알루미늄 이온 등으로 이루어진 군에서 선택된 1종 이상일 수 있으며, 예컨대, 망간 이온, 철 이온, 및 코발트 이은로 이루어진 군에서 선택된 1종 이상일 수 있다. 상기 금속 이은의 첨가량이 0.1 mM 미만인 경우에는 사이코스 생산 수율 증진 효과가 미미하므로, 상기 금속 이온의 첨가량은 O.lmM 이상으로 할 수 있다. 한편, 상기 금속 이온의 첨가량이 5mM을 초과하면 그 초과량에 비하여 효과가 미미하기 때문에, 상기 금속 이온의 첨가량은 5mM 이하로 할 수 "있다. 예컨대, 상기 금속 이온의 첨가량은 O.lmM 내지 5mM, 예컨대, 0.1 내지 2mM, 또는 0.5 mM 내지 1.5mM 범위로 할 수 있다. 따라세 상기 사이코스 제조용 조성물은 첨가량은 상기한 금속 이온을 추가로 포함할 수 있으며, 금속 이온의 종류와 함량은 상기한 바와 같다. 또한, 상기 사이코스 생산 방법은 금속 이은을 첨가하는 단계를 추가로 포함할 수 있으며ᅳ 금속 이온의 종류와 함량은 상기한 바와 같다. 일 구현예에서, 상기 금속 이온은 기질인 과당에 첨가되거나, 상기 효소 단백질 등과 과당과의 흔합물에 첨가될 수 있다. 또 다른 구현예에서, 상기 금속 이온은 상기 효소 단백질 등이 고정화된 담체에 첨가되거나 (과당 첨가 전). 상기 효소 단백질 등이 고정화된 담체와 과당과의 흔합물에 첨가되거나 (과당 첨가 후), 또는 과당 첨가시에 과당과 흔합물의 형태로 또는 각각 첨가될 수 있다. 재조합 균주를 사용하는 경우, 상기 금속 이온이 배양물에 첨가되거나 금속 이온이 첨가된 배양 배지에서 배양아 수행될 수 있다. The enzymatic protein having the cyclase converting enzyme activity may be one having a metalloenzyme property in which activation is controlled by metal ions. By performing the reaction by the enzyme protein in the presence of metal, it is possible to enhance the yield of the production of the cycle. The metal ions that may contribute to the sacos production yield may be at least one selected from the group consisting of copper ions, manganese ions, calcium silver, magnesium silver, zinc silver, nickel silver, cobalt ions, iron silver, aluminum ions, and the like. It may be at least one selected from the group consisting of manganese ions, iron ions, and cobalt silver. When the amount of the metal silver added is less than 0.1 mM, since the effect of improving the yield of the cycle course production is insignificant, the amount of the metal ion added may be at least O.lmM. On the other hand, if the amount of the metal ion exceeds 5mM because the effect is insignificant compared to the excess amount, the amount of the metal ions can "be less than 5mM. For example, the amount of the metal ions to 5mM O.lmM For example, 0.1 to 2 mM, or 0.5 mM to 1.5 mM. Accordingly, the composition for preparing the psychos may further include the above-described metal ions, and the type and content of the metal ions are as described above. In addition, the method of producing a psychos may further include the step of adding metal silver and the type and content of metal ions are as described above. In one embodiment, the metal ion may be added to the fructose as a substrate, or may be added to a mixture of the enzyme protein and the fructose. In another embodiment, the metal ion is added to the carrier to which the enzyme protein or the like is immobilized (before fructose addition). The enzyme protein or the like may be added to the mixture of the immobilized carrier and fructose (after fructose addition), or may be added in the form of fructose and the combination at the time of fructose addition, or respectively. When using a recombinant strain, the metal ion may be added to the culture or cultured in a culture medium to which the metal ion is added.
상기 담체는 고정된 효소 단백질의 활성이 장기간 유지될 수 있는 환경을 조성할 수 있는 것으로, 효소 고정화 용도로 사용할 수 있는 공지된 모든 담체일 수 있다. 예컨대, 상기 담체로서 알긴산나트륨 (soduim alginate)을 사용할 수 있다. 알긴산나트륨은 해조류의 세포벽에 풍부하게 존재하는 천연 콜로이드성 다당류로, 만누로닉산 (β-으 mannuronic acid)과 글루로닉산 (α—ᄂ- gluronic ackl)이 조성되어 있고, 함량면에서는 무작위로 베하 -1,4 결합을 이루아 형성되어, 균주 또는 효소가 안정적으로 고정되어 우수한 사이코스 수율을 나타내는 데 유리할 수 있다. 일 구체예에서, 사이코스의 수율을 보다 증진시키기 위하여 1.5 내지 4.0%(w/v) 농도의 알긴산나트륨 용액 (예컨대, 알긴산나트륨 수용액), 예컨대 약 2.5%의 (w/v) 농도의 알긴산나트륨 용액을 균주의 고정화에 사용할 수 있다.  The carrier may create an environment in which the activity of the immobilized enzyme protein can be maintained for a long time, and may be any known carrier that can be used for enzyme immobilization. For example, sodium alginate may be used as the carrier. Sodium alginate is a natural colloidal polysaccharide that is abundant in algae cell walls. It contains mannuronic acid (β- mannuronic acid) and gluronic acid (α—b-gluronic ackl), which are randomly selected. It is formed by forming a -1,4 bond, it may be advantageous to stably fix the strain or enzyme to show a good psychocos yield. In one embodiment, a sodium alginate solution (e.g. aqueous sodium alginate solution) at a concentration of 1.5 to 4.0% (w / v), such as sodium alginate at a concentration of about 2.5% The solution can be used for immobilization of the strain.
일 구현 예에 있어서, 상기 사이코스의 생산 방법은, 서열번호 1의 아미노산 서열, 또는 상기 서열번호 1의 아미노산 서열과 70% 이상의 상동성이 있는 아미노산 서열을 갖는 사이코스 3ᅳ에피머화 효소 단백질을 과당과 반웅시키는 단계를 포함하는 것일 수 있다. 상기 사이코스 생산 방법은 상기 반웅 단계 이전에 서열번호 1의 아미노산 서열, 또는 상기 서열번호 1의 아미노산 서열과 70% 이상의 상동성이 있는 아미노산 서열을 갖는 사이코스 3-에피머화 효소 단백질을 준비 및 /또는 정제하는 단계를 추가로 포함할 수 있다. ' In one embodiment, the method for producing the psychocos, the Pseudomonas 3 'epimerase protein having an amino acid sequence of SEQ ID NO: 1, or an amino acid sequence of at least 70% homology with the amino acid sequence of SEQ ID NO: 1 It may include the step of reacting with fructose. Said psychos production method Adding and / or purifying the Pseudo-3 epimerase enzyme protein having an amino acid sequence of SEQ ID NO: 1 or an amino acid sequence of at least 70% homology with the amino acid sequence of SEQ ID NO: 1 before the reaction step It can be included as. '
다른 일 구현 예에 있어서, 상기 사이코스의 생산 방법은 서열번호 1의 아미노산 서열을 가지는 단백질을 발현하는 재조합 균주 또는 상기 계조합 균주로부터 분리된 효소 단백질을 과당과 반응시키는 단계를 포함하는 것일 수 있다. 상기 사이코스 생산 방법은 상기 반움 단계 이전에 서열번호 1의 아미노산 서열을'가지는 단백질을 발현하는 재조합 균주를 배양 및 회수하는 단계를 추가로 포함할 수 있다. In another embodiment, the method of producing the psycos may include the step of reacting with a fructose a recombinant strain expressing a protein having an amino acid sequence of SEQ ID NO: 1 or an enzyme protein isolated from the system combination strain with fructose. . The psicose production method may include the further step of culturing, and recovering the recombinant strain expressing a protein of amino acid sequence of SEQ ID NO: 1 in the previous step the banum.
상기 재조합 균주의 배양 단계는 사용되는 균주 (숙주세포)의 특성에 따라 관련 기술 분야의 당업자에 의해 용이하게 선택되는 배지 및 배양 조건 하에서 이루어질 수 있다. 예를 들어, 상기 배양은 연속, 반연속, 또는 회분식 배양일 수 있지만 이 방법들에 한정된 것은 아니다 · 상기 배지로서는 대장균을 비롯한 임의의 숙주 세포, 및 세포 내용물을 지지하거나 또는 함유할 수 있는 임의의 배양 배지, 용액, 고체, 반고체 또는 강성 지지체를 포함하며ᅳ 예컨대.The culturing step of the recombinant strain may be performed under medium and culture conditions which are easily selected by those skilled in the art according to the characteristics of the strain (host cell) used. For example, the culture may be continuous, semi-continuous, or batch culture, but is not limited to these methods. The medium may be any host cell, including E. coli, and any cell that may contain or contain cell contents. Culture media, solutions , solids, semisolids or rigid supports;
2YT 배지, LB 배지, SOB 배지, TB 배지 등으로 이루어진 군에서 선택된 것일 수 있다. It may be selected from the group consisting of 2YT medium, LB medium, SOB medium, TB medium and the like.
상기 재조합 균주와 배양물은 일반적으로 숙주 세포 (예컨대, 대장균)올 배양하는데 적합한 조건을 사용하여 얻어질 수 있다. 예를 들면, 상기 재조합 균주를 35 °C 내지 37°C 및 150 내지 250rpm 조건 하에서 진탕 배양하여 배양물을 얻을 수 있다. 또한, 상기 효소 단백질의 과발현을 유도하기 위하여 당업계에서 통상적으로 사용하는 유도 물질을 첨가할 수 있다. 예를 들면, 상기 유도 요소가 lac 오페론 또는 trc 포로모터인 경우, Lactose 나 IPTG (이소프로필 β-D-l-티오갈락토티오피라노시드)일 수 있으며, 상기 유도 시기는 당업자에 의하여 배양의 적절한 시기에 이루어질 수 있다. 상기 재조합 균주는 상기 얻어진 배양물을 원심분리 및 /또는 여과 등을 수행하여 얻을 수 있으며ᅳ 또한 상기 얻어진 균주를 균질화시키고 원심 분리하여 수득된 상층액 또는 상기 상층액을 분획화하거나. 크로마토그래피 등을 통해 정제하여 효소 단백질을 얻을 수 있다. 예컨대, 회수된 균주를 50mM 인산 완충용액으로 현탁한 후 파쇄하여 원심분리 한 후, 상등액만 '니켈 -N.TA 컬럼 (Qiagen) 에서 흡착시킨 후 20mM.250mM 이미다출의 농도로 효소 단백질을 회수할 수 있다. Such recombinant strains and cultures can generally be obtained using conditions suitable for culturing host cells (eg, E. coli). For example, the recombinant strain may be cultured by shaking culture under conditions of 35 ° C to 37 ° C and 150 to 250 rpm. In addition, an inducer commonly used in the art may be added to induce overexpression of the enzyme protein. For example, when the inducing element is a lac operon or trc promoter, it may be Lactose or IPTG (isopropyl β-Dl-thiogalactopiopyranoside), and the induction period may be an appropriate time of culture by a person skilled in the art. Can be done on. The recombinant strain may be obtained by performing centrifugation and / or filtration of the obtained culture, and further, fractionating the supernatant or the supernatant obtained by homogenizing and centrifuging the obtained strain. Purification by chromatography can be used to obtain enzyme proteins. For example, a suspension of the recovered strains in 50mM phosphate buffer and then homogenized and then centrifuged, only the supernatant to recover the 20mM.250mM already enzyme protein at a concentration of dachul after absorption in the '-N.TA nickel column (Qiagen) Can be.
상기 과당과 반응시키는 단계는 상기 효소 단백질의 최적 활성화 조건 하에 이루어질 수 있다. 예컨대 pH 6 내지 9, H 6.8 내지 9.0, pH 7 내지 9, pH 6.8 내지 8.5, pH 7 내지 8.5, pH 6.8 내지 8.0, 또는 pH 7 내지 8, 및 /또는 40 °C 내지 65°C 또는 50°C 내지 65°C의 온도 조건하에 이루어지는 것일 수 있다. 상기 과당은 전체 반웅물 기준으로 40 내지 75%(w/v), 예컨대 50 내지 75%(w/v)의 농도로 사용될 수 있다. - 상기 범위로 과당을 사용함으로써 보다 경제적이며 효율적으로 사이코스를 생산할 수 있다. The step of reacting with fructose can be carried out under optimal activation conditions of the enzyme protein. Such as pH 6-9, H 6.8-9.0, pH 7-9, pH 6.8-8.5, pH 7-8.5, pH 6.8-8.0, or pH 7-8, and / or 40 ° C.-65 ° C. or 50 ° It may be made under a temperature condition of C to 65 ° C. The fructose may be used at a concentration of 40 to 75% (w / v), such as 50 to 75% (w / v), based on the total counterungmul. By using fructose in the above range, it is possible to produce psychocos more economically and efficiently.
또한 재조합 균주를 사용할 경우 바람직하게는 과당과 반웅시키기 전에 상기 회수된 균체를 예컨대, 0.85%(w/v) NaCl 등을 사용하여 2회 이상 세척하여 사용할 수 있다.  In the case of using a recombinant strain, preferably, the recovered cells may be washed two or more times with, for example, 0.85% (w / v) NaCl or the like before reacting with fructose.
또.한 바람직하게는 상기 과당과 반웅시키는 단계는 망간 및 코발트로 이루어진 군에서 선택된 1종 이상의 금속의 이온을 더욱 첨가하여 이루어질 수 있다. 상기 금속 이온은 O.lmM 내지 5mM, 예컨대, 0.1 내지 2mM, 또는 0.5 mM 내지 1.5mM 범위로 첨가할 수 있다. 상기 범위에 미달할 경우 활성 증가 효과를 충분히 얻을 수 없으며ᅳ 상기 범위를 초과할 경우 사용되는 양에 비해 얻게 되는 활성 증대 효과가 미미하여 바람직하지 않다.  Also preferably, the step of reacting with fructose may be performed by further adding ions of at least one metal selected from the group consisting of manganese and cobalt. The metal ions may be added in the range of O.lmM to 5 mM, such as 0.1 to 2 mM, or 0.5 mM to 1.5 mM. If it is less than the above range, the effect of increasing the activity cannot be sufficiently obtained, and if it exceeds the above range, the effect of increasing the activity obtained compared to the amount used is not preferable.
본 발명의 방법에 의하여 과당으로부터 수득된 사이코스는 통상적인 방법에 의해 정제될 수 있으며, 이러한 결정은 당업자에게 통상적인 기술에 속한다ᅳ 예를 들어 원심분리, 여과, 결정화, 이온교환 크로마토그래피 및 이들의 조합으로 이루어진 군으로부터 선택된 하나 이상의 방법에 의하여 미루어질 수 있다. Psychoses obtained from fructose by the method of the present invention can be purified by conventional methods, and such crystals are well known to those skilled in the art. For example, by one or more methods selected from the group consisting of centrifugation, filtration, crystallization, ion exchange chromatography, and combinations thereof.
【발명의 효과】 -본 발명에 따른 신규한 사이코스 께피머화 효소는 과당의 3번째 탄소 위치를 에피머화하여 사이코스를 생산하는 활성을 보유한. 효소로써, 열안정성이 우수하고 반감기가 길며 산업적으로 적용 가능한 조건에서 높은 수율로 과당으로부터 사이코스의 대량 생산이 가능하므로, 사이코스 제조를 위한 산업적 이용에 유용하다. 본 발명의 D-사이코스 3-에피머화 효소와 이를 이용한 사이코스 생산방법은 기능성당 산업뿐만 아니라 이를 이용한 건강식품소재, 의약용, 화장품용 소재 등 유용하게 사용될 것으로 기대된다. 【발명을 실시하기 위한 구체적인 내용】  [Effect of the Invention]-The novel cosmos gepymerase according to the present invention possesses the activity of producing a psychose by epimerizing the third carbon position of fructose. As an enzyme, it is useful for the industrial use for the production of psychos, because it is possible to mass-produce cyclose from fructose in high yield under conditions of excellent thermal stability, long half-life and industrially applicable conditions. The D-psicose 3-epimerase of the present invention and the method of producing a psychos using the same are expected to be usefully used as well as in the functional sugar industry, as well as health food materials, pharmaceuticals and cosmetic materials using the same. [Specific contents to carry out invention]
이하 본 발명을 구체적인 실시 예에 의해 더 상세히 설명하고자 한다. 하지만 본 발명은 하기 실시 예에 한정돤 것이 아니며, 본 발명의 사상과 범위 내에서 여러 가지 변형 또는 수정이 가능함은 이 분야에서 당업자에게 명백한 것이다. 따라서, 첨부된 청구항들은 넓게 본 발명의 사상과 범위에 부합되게 해석되어야 한다  Hereinafter, the present invention will be described in more detail with reference to specific examples. However, the present invention is not limited to the following examples, and various modifications or changes are possible to those skilled in the art within the spirit and scope of the present invention. Accordingly, the appended claims should be construed broadly according to the spirit and scope of the present invention.
실시예 1. D-사이코스 3-에피머화 효소를 생산하는 재조합균주의 제조 크로스트리디움 신댄스 sc^ci?/7s)로부터 유래된 서열번호Example 1 Preparation of Recombinant Strain Producing D-Pycos 3-Epimerase Enzyme Sequence Number Derived from Crosstridium Syndance sc ^ ci? / 7s)
1의 아미노산 서열을 암호화하는 폴리뉴클레오티드로서, 발현 균주로 사용될 대장균에 최적화되도록 원래의 암호화 폴리뉴클레오타이드 (서열번호 3)의 염기서열에 변형이 가해진 폴리뉴클레오타이드 (서열번호 2)를 바이오니아 (Bioneer.Co.Korea)에 의뢰하여 합성하였다. A polynucleotide encoding the amino acid sequence of 1, wherein a polynucleotide (SEQ ID NO: 2) having a modification to the nucleotide sequence of the original coding polynucleotide (SEQ ID NO: 3) is optimized for E. coli to be used as an expression strain. Korea) to synthesize.
상기 합성된 폴리뉴클레오티드를 제한효소 Ndel과 XhoKNEB)을 사용하여 발현백터인 pET21a(Novagen)의 동일한 제한효소 부위에 삽입하여 재조합 백터 pET21a/사이코스 에피머화 효소 (pET-CDPE)를 제조하였다. 상기 제조된 재조합 백터 pET-CDPE를 도 1에 개시하였다. The synthesized polynucleotide was inserted into the same restriction enzyme site of pET21a (Novagen), which is an expression vector using restriction enzymes Ndel and XhoKNEB). Recombinant vector pET21a / Phycose epimerase (pET-CDPE) was prepared. The recombinant vector pET-CDPE prepared above is shown in FIG. 1.
heat shock방법 (Sambrook and Russell: Molecular Cloning.)에 의하여 대장균 BL21(DE3)(invitrogen)를 상기 제조된 재조합 백터 pET-CDPE로 형질전환 하여 재조합 균주를 제조하였다.  E. coli BL21 (DE3) (invitrogen) was transformed with the recombinant vector pET-CDPE prepared above by a heat shock method (Sambrook and Russell: Molecular Cloning.) to prepare a recombinant strain.
상기 제조된 재조합 균주를 5ml LB-ampicilline 배지 (Difco)에 접종한 후 600nm에서의 흡광도 (OD)가 1.5에 도달할 때까지 37°C, 200rpm에서 진탕 배양하고, 이를 다시 500ml LB-ampicilline 배지에 접종한 후 37°C의 진탕 배양기에서 종 배양하였다. 이 배양액의 600nm에서 흡광도가 0.5일 때 ImM의 IPTG(isopropyl-l— thio-β— D-galactopyranoside)를 첨가하여 목적 효소의 과발현을 유도하였다. 상기 과발현 유도 시점부터 배양조건을 16*0 및 150rpm으로 전환하여 16시간 동안 유지하였다. After inoculating the prepared recombinant strain in 5ml LB-ampicilline medium (Difco) and shaking culture at 37 ° C, 200rpm until the absorbance (OD) at 600nm reaches 1.5, it was again in 500ml LB-ampicilline medium After inoculation, species cultured in a shaker at 37 ° C. When the absorbance was 0.5 at 600 nm of this culture, IPM (isopropyl-l-thio-β-D-galactopyranoside) of ImM was added to induce overexpression of the target enzyme. From the time of induction of overexpression, the culture conditions were switched to 16 * 0 and 150rpm and maintained for 16 hours.
상기 과발현이 유도된 배양액을 원심분리기 4000rpm에서 20분간 원심 분리하여 균체만을 회수하였다. 회수한 균체는 0.85%(w/v) NaCl로 2회 세척 후 하기하는 효소 정제에 사용하였다.  The overexpression-induced culture was centrifuged in a centrifuge 4000rpm for 20 minutes to recover only the cells. The recovered cells were washed twice with 0.85% (w / v) NaCl and used for the following enzyme purification.
상기 제조된 재조합 균주는 Escherichia co//-pETCDPE_SYG321로 명명하고, 2013년 3월 29일자로 한국미생물보존센터에 기탁하여 기탁번호 KCCM11406P를 부여받았다. 실시예 2. D-사이코스 3-에피머화효소정제 및 특성 확인  The prepared recombinant strain was named Escherichia co //-pETCDPE_SYG321 and deposited on March 29, 2013 with the Korea Microorganism Conservation Center and received accession number KCCM11406P. Example 2. Purification and Characterization of D-Pycos 3-Epimerase
2-1. D-사이코스 3-에피머화효소의 정제  2-1. Purification of D-Pycos 3-Epimerase
상기 실시예 1에서 회수된 균체를 lysis buffer(50mM Tris_HCl 300mM NaCl pH8.0, 10 mM imidazol)에 흔탁시킨 후 음파진동기 (Ultrasonic processor. ColepParmer)를- 사용하여 4°C에서 20분 동안 파쇄하였다. 파쇄액을 13,000rpm에서 20분 동안 원심 분리하여 상등액만을 모은 후, 미리 lysis buffer로 평형시킨 Ni— NTA컬럼 (Ni— NTA Superflow. Qiagen)에 적용시킨 다음, 50mM Tris_HCl 300mM NaCl pH8.0에 20 mM imidazol과 250 mM imidazol이 함유된 완충용액을 순차적으로 홀려 주었다. 상기 50mM Tris_HCl 300mM NaCl pH8.0, 250 mM imidazol을 홀려주는 과정에 의하여 목적 단백질을 분리 정제하였다. The cells recovered in Example 1 were suspended in lysis buffer (50 mM Tris_HCl 300 mM NaCl pH8.0, 10 mM imidazol) and then disrupted at 4 ° C. for 20 minutes using an ultrasonic processor (ColpParmer). The lysate was centrifuged at 13,000 rpm for 20 minutes to collect only the supernatant, and then placed in a Ni—NTA column (Ni— NTA Superflow. Qiagen) previously equilibrated with lysis buffer. After application, the buffer solution containing 20 mM imidazol and 250 mM imidazol in 50 mM Tris_HCl 300 mM NaCl pH8.0 was sequentially poured. The 50 mM Tris_HCl 300 mM NaCl pH8.0, 250 mM imidazol by the process of blowing the target protein was isolated and purified.
상기 분리 정제된 목적 단백질은 효소 활성 측정용 완충용액 (50mM The isolated purified protein of interest (50mM buffer for enzyme activity measurement)
PIPES pH7.5)으로 전환한 다음 실험에 사용하였다. 또한 상기 분리 (부분) 정제된 목적단백질인 사이코스 에피머화 효소는 SDS-PAGE를 통하여 단량체의 크기가 약 32.8 kDa인 것으로 확인되었다. - 2-2. D-사이코스 3-에피머화효소의 금속이은요구성 분석 PIPES pH7.5) was used for the experiment. In addition, the isolated (partially) purified protein of Pseudomonas epimerase was found to have a monomer size of about 32.8 kDa through SDS-PAGE. -2-2. Metal Grain Constituent Analysis of D-Pycos 3-Epimerase
기존에 알려진 타가토스 또는 사이코스 3-에피머화 효소는 금속이온 요구성이 있는 것으로 알려져 있다. 상기 실시예 2-1에서 얻어진 D-사이코스 에피머화 효소에 대해서도 금속이온이 영향을 미치는지 알아보았다.  Tagatose or Pycos 3-epimerase known in the art is known to have metal ion requirements. It was examined whether metal ions also affect the D-psicose epimerase obtained in Example 2-1.
.상기 실시예 2-1에서 정제된 단백질 (효소)에 금속이은 CuCl2, MnCl2, CaCl2. ZnS04, MgS04, NiS04, 또는 CoCl2를 각각 1 mM씩 처리하여 효소 활성을 측정하였다. 상기 효소 활성 측정은 상기 금속 이온 존재 하에서 50 mM 과당과 효소 0.3 unit/ml 이 50mM PIPES 완충용액 (pH7,0)에서 60°C, 5분간 반웅한 것을 측정한 것이다. 상기 반웅 후 100°C에서 5분간 가열하여 효소 활성을 중지시켰다. 상기 효소 활성은 기질인 50 mM 과당과 ImM Co2+ 을 함유한 50mM PIPES 완충용액 pH7.0을 60°C에서 효소와 반웅시켜 분당 imol(micromole)의 사이코스를 생산하는 양을 lunit으로 정의하였다. 대조군 (Non)으로 금속이온을 처리하지 않은 것을 사용하였다. .The metal silver is CuCl 2 , MnCl 2 , CaCl 2 in the protein (enzyme) purified in Example 2-1. Enzyme activity was measured by treating 1 mM of ZnSO 4 , MgSO 4 , NiSO 4 , or CoCl 2 , respectively. The enzyme activity was measured by measuring 50 mM fructose and 0.3 unit / ml of enzyme in the presence of metal ions at 60 ° C. for 5 minutes in 50 mM PIPES buffer solution (pH7,0). After the reaction was heated for 5 minutes at 100 ° C to stop the enzyme activity. The enzyme activity was defined as lunit by the amount of 50 mM fructose and 50 mM PIPES buffer pH7.0 containing ImM Co 2+ , reacted with the enzyme at 60 ° C. to produce an imol (micromole) cyclase per minute as lunit. . As a control group (Non), a metal ion was not treated.
상기 효소 활성은 생산된 사이코스 양 (mM)을 사용된 효소양과 반웅시간으로 나누어서 계산하였으며, 사이코스 양은 HPLC로 분석하였다. 상기 HPLC 분석은 87C(BIO- AD) 컬럼을 사용하여 8CTC에서, 이동상으로 물 100%(v/v)를 0.6 ml/min 유속으로 흘려 주면서 수행하였으며, Refractive Index Detector(Agilent 1260 TID)로 사이코스를 검출하여 사이코스 생산성을 분석하였다. ᅳ The enzymatic activity was calculated by dividing the amount of psychos produced (mM) by the amount of enzyme used and reaction time, and the amount of psychos was analyzed by HPLC. The HPLC analysis was performed at 8CTC using a 87C (BIO-AD) column, flowing 100% (v / v) of water at a flow rate of 0.6 ml / min into the mobile phase, Refractive Psychoproductivity was analyzed by index detector (Agilent 1260 TID). ᅳ
상기 측정된 각 금속 이은을 처리한 경우의 효소 활성을 대조군에서의 효소 활성과 비교하여 도 2에 나타냈다. 도 2에 나타난 바와 같이, 실시예 2- 1의 효소는 망간이온, 철이은 및 코발트이온 첨가에 의하여 활성이 증가하는 것으로 나타나 금속 이온 요구성이 있음을 알 수 있다.  Enzyme activity in the case of treating each metal silver measured as described above is shown in FIG. 2 compared to the enzyme activity in the control group. As shown in FIG. 2, the enzyme of Example 2-1 was found to increase in activity by the addition of manganese ions, iron silver and cobalt ions, indicating that the metal ions were required.
2-3.사이코스 에피머화효소의 은도, pH 변화에 따른활성 분석 2-3.Analysis of Psychoepimerase by Activity
상기 실시예 2-1에서 정제된 효소의 pH 및 온도변화에 따른 활성을 확인하기 위해, 다양한 pH 및 은도에서 효소와 과당 기질을 반웅시키고 효소 활성을 확인하였다. 이 때 활성측정은, 상기 실시예 2.2에 기재된 방법을 참조하여. 50 mM 과당과 효소 0.3 unit/ml을 사용하여 pi— I 4 내지 9 및 온도 In order to confirm the activity according to the pH and temperature change of the enzyme purified in Example 2-1, the enzyme and fructose substrate were reacted at various pH and silver and the enzyme activity was confirmed. At this time, for activity measurement, refer to the method described in Example 2.2. Pi—I 4 to 9 and temperature using 50 mM fructose and enzyme 0.3 unit / ml
30 내지 80°C 범위에서 5분간 이루어졌으며, 그 후 lOCrc에서 5분간 가열하여 반웅을 중지시켰다. The reaction took place for 5 minutes in the range of 30-80 ° C., after which the reaction was stopped by heating in lOCrc for 5 minutes.
먼저 pH를 7로 하고 온도를 30 내지 80 °C 범위에서 변화시키며 상기 실시예 2-2와 동일한 방법으로 효소 활성을 측정한 결과를 도 3에 나타내었다. 도 .3의 Y축의 상대적 활성은 가장 좋게 나온 효소 활성을 100으로 하였을 때의 상대값을 의미한다. First, the pH was changed to 7 and the temperature was changed in the range of 30 to 80 ° C., and the result of measuring enzyme activity in the same manner as in Example 2-2 is shown in FIG. 3. The relative activity of the Y axis in FIG. 3 means a relative value when the best enzyme activity is 100.
도 3에서 확인되는 바와 같이, 상기 효소는 40 내지 65°C, 구체적으로 50 내지 65°C 범위에서 높은 활성을 나타냈으며, 특하 60°C에서 최대 활성을 보임을 알 수 있다. As confirmed in Figure 3, the enzyme showed a high activity in the range of 40 to 65 ° C, specifically 50 to 65 ° C, it can be seen that the maximum activity at 60 ° C. in particular.
또한 , pH 변화에 따른 활성을 알아보기 위해, 상기 실시예 2.2에 기재된 방법을 참조하여, 60°C에.서, 50mM 소듐 아세테이트 pH 4-6,.50 mM 소듐 시트레이트 pH 5-7, 50mM PIPES(piperazine-N,N'-bis(2-ethanesulfonic acid) pH 7.50 mM Tris-HCl pH 7-9, 및 50 mM 글라이신 NaOH pH 9- 10의 완충용액을 각각 사용하여 효소 활성을 측정하였다. 상기 얻어진 결과를 도 4에 나타내었다. . · , 도 4에서 확인되는 바와 같이. pH 7.0-9.0 범위, 그 중 pH7.0에서 효소 활성이 특히 높게 나타났다. 또한 PH 7.0에 해당되는 완층용액 중에서도Further, with reference to the method described in Example 2.2, to 60 ° C., Standing, 50mM sodium acetate pH 4-6, to determine their activity according to the pH change. Buffer solution of 50 mM sodium citrate pH 5-7, 50 mM piperazine-N, N'-bis (2-ethanesulfonic acid) pH 7.50 mM Tris-HCl pH 7-9, and 50 mM glycine NaOH pH 9-10 The enzyme activity was measured using each of the results. 4 is shown. . , As confirmed in FIG. 4. The enzyme activity was particularly high in the pH 7.0-9.0 range, pH7.0. In addition, among the complete solution corresponding to PH 7.0
PIPES 완충용액에서 효소 활성이 보다 우수한 것으로 나타났다. Enzyme activity was shown to be better in PIPES buffer.
상기 시험에서 효소 활성이 우수한 것으로 나타난 PIPES 완충 용액에 대해 pH 별로 활성을 측정하여 도 5에 나타내었다.  It was shown in Figure 5 by measuring the activity for each pH for the PIPES buffer solution that showed excellent enzyme activity in the test.
도 5와 같이 pH 7.0 이상, 예컨대 pH 7.5 정도에서 높은 활성을 나타내었다. 2-4. 사이코스 에피머화효소의 기질 특이성 분석  As shown in FIG. 5, high activity was exhibited at pH 7.0 or higher, such as pH 7.5. 2-4. Substrate Specificity Analysis of Cycos Epimerase
50 mM 농도의 기질. 즉, 과당, 사이코스 (Psicose), 타가토스, 만노스. 포도당, 또는 자일로스를 각각 기질로 하여 1 mM CoCl2와 상기 실시예 2- 1에서 정제된 효소 0.3 unit/ml을 포함하는 50 mM PIPES 완충용액에서 pH 7.5 및 60°C 조건하에서 5분간 반웅시켜 각각의 기질에 대한 활성 정도를 측정하였다. 효소활성은 100°C에서 5분간 가열하여 중지시켰다. Substrate at 50 mM concentration. That is, fructose, Psicose, tagatose, mannose. Glucose or xylose was used as a substrate and reacted for 5 minutes under pH 7.5 and 60 ° C. in 50 mM PIPES buffer solution containing 1 mM CoCl 2 and 0.3 unit / ml of the enzyme purified in Example 2-1. The degree of activity for each substrate was measured. Enzyme activity was stopped by heating at 100 ° C for 5 minutes.
상기 얻어진 결과를 아래의 표 1에 나타내었다 (사이코스를 기질로 하는 반웅의 효소 활성을 100으로 한상대값으로 나타냄).  The results obtained above are shown in Table 1 below (enzymatic activity of Banung, which is based on Psychos as a substrate, is expressed as a relative value of 100).
【표 1】  Table 1
Figure imgf000019_0001
상기 표 1에 나타난 바와 같이, 실시예 2-1에서 정제된 효소는 여러가지 기질 중에서 사이코스와 과당에서만 특이적으로 활성을 보였으며 , 특히 사이코스의 기질 특이성이 과당과 비교했을 때 약 32% 높은 것으로 나타났다. 기존에 알려진 케토오스 3-에피머화 효소는 사이코스와 과당뿐만 아니라 타가토스와 솔보스에도 반응성이 있는 것에 비하여, 본 발명의 효소는 사이코스와 과당에만 특이적이게 반웅하는 특징이 있어 기존에 알려진 효소와 기질 특이성이 상이함을 확인할 수 있다. 2-5. 사이코스 에피머화효소의 열 안정성 분석
Figure imgf000019_0001
As shown in Table 1, the enzyme purified in Example 2-1 showed only specific activity among cyclose and fructose among various substrates, and in particular, the substrate specificity of psychose was about 32% higher than that of fructose. Appeared. Known ketose 3-epimerase enzymes are known for In addition, it is confirmed that the enzyme of the present invention has a characteristic that only reacts specifically to psychos and fructose, and thus, the enzyme and the substrate specificity are different from those known to the tagatose and the sorbose. 2-5. Thermal Stability Analysis of Psychos Epimerase
은도변화에 따른 사이코스 3-에피머화 효소의 안정성을 확인하기 위해, 상기 실시예 2— 1에서 정제된 효소를 5C C에서 일정시간 (9시간) 열처라 한 후, 50 mM의 과당을 기질로 하여 1 mM CoCl2와 효소 0.3 unit/ml이 포함된 50 mM PIPES 완층용액에서 pH 7.5 및 50°C 조건 하에서 5분 동안 반응시켜 효소 활성을 측정하였다. 효소 활성은 100°C에서 5분간 가열하여 중지시켰다. 상기 열처리 시간에 따라서 얻어진 결과를 도 6에 나타내었다. 도 6에서와 같이, 실시예 2ᅳ 1에서 정제된 효소는 9시간까지 활성이 크게 감소하지 않았으며, 반감기는 약 20 시간으로 계산 되.었다. 기존에 보고된 사이코스 3-에피머화 효소들은 대부분 50°C에서 반감기가 대략 한 시간 정도인 것에 비해, 본 발명의 효소는 동일한 은도에서 열안정성이 우수함을 확인 할 수 있다. In order to confirm the stability of the Pseudomonas 3-epimerase according to the degree of silver change, the enzyme purified in Example 2-1 above was heated for 5 hours at 5C C, and then 50 mM fructose was used as a substrate. The enzyme activity was measured by reacting 1 mM CoCl 2 with a 50 mM PIPES complete solution containing 0.3 unit / ml of enzyme under pH 7.5 and 50 ° C. for 5 minutes. Enzyme activity was stopped by heating at 100 ° C for 5 minutes. The results obtained according to the heat treatment time are shown in FIG. 6. As shown in Figure 6, the enzyme purified in Example 2-1 did not significantly decrease the activity until 9 hours, the half-life is calculated to about 20 hours . It was. It is confirmed that the previously reported psychos 3-epimerase enzymes have a half-life of approximately one hour at 50 ° C., whereas the enzyme of the present invention has excellent thermal stability in the same silver.
2-6.사이코스 에피머화효소의 반웅속도 (Kinetic parameter)분석 2-6.Kinetic Parameter Analysis of Cycos Epimerase
실시예 2-1에서 정제한 크로스트리디움 산^스 CJostrkn'um sc//7t/e;7s)유래와 사이코스 에피머화 효소의 효소 반웅속도를 살펴보기 위해 kinetic parameter 분석을 실시하였다 (Zhu Y. et. a/.(2012), Kim HJ. et. a/(2006), Mu W. et.3/(2011)) Kinetic parameter analysis was performed to examine the enzyme reaction kinetics of the crosstridium acid ^ CJostrkn ' um sc // 7t / e; 7s) purified in Example 2-1 and the cosmos epimerase (Zhu Y et.a /. (2012), Kim HJ. et.a / (2006), Mu W. et. 3 / (2011))
기질인 과당의 농도를 5 내지 250 mM 범위에서 변화시키면서, 실시예 2-1의 효소 0.3 unit/ml 및 1 mM C0CI2이 첨가된 50 mM PIPES 완충용액 ,pH7.5 및 60°C 조건 하에서 반웅시켜 효소 활성을:측정하였다. KX C에서 5분간 가열하여 효소 활성을 중지시켰다. 효소 반웅속도를 단량체로 계산했을 경우 과당의 Km 값은 56 mM이고 kcat은 10128.6 mir 1이었다, 상기 효소 반웅 속도는 michaelis— mentenequation에 근거하여 계산하였다. Reacting under the conditions of 50 mM PIPES buffer, pH 7.5 and 60 ° C. to which 0.3 unit / ml of enzyme of Example 2-1 and 1 mM C0CI 2 were added while varying the concentration of fructose as a substrate in the range of 5 to 250 mM. Enzyme activity was measured. Enzyme activity was stopped by heating at KX C for 5 minutes. When the enzyme reaction rate was calculated as a monomer, the Km value of fructose was 56 mM and kcat was 10128.6 mir 1. The enzyme reaction rate was calculated based on michaelis—mentenequation.
즉 실시예 2-1의 사이코스 3-에피머화 효소의 과당에 대한 촉매효율 (catalytic efficiency)은 286.28 로써, 기존에 발표된 사어코스 에피머화 효소 중 촉매효율이 가장 높은 것으로 보고된 아그로박테리움 투메패시언스 유래의 사이코스 3ᅳ에피머화 효소의 촉매효율¾ 85보다도 약 3.3배 이상높은 것으로 나타났다.  In other words, the catalytic efficiency of fructose of the Pseudomonas 3-epimerase of Example 2-1 was 286.28, which is the highest reported catalytic efficiency among the previously reported Sarcos epimerase. It was found to be about 3.3 times higher than the catalytic efficiency ¾ 85 of the psychic 3 ᅳ epimerase derived from mechasion.
그러므로 본 발명의 효소는 산업적으로 반응이 용이한 온 H (약 50~60°C)에서 반웅 속도가 매우 빨라 사이코스 생산 속도 측면에서 이점을 가지고 있어 사이코스 산업화에 탁월한 효과를 기대할 수 있다. 실시예 3. D-사이코스 3-에피머화 효소에 의한사이코스 생산 Therefore, the enzyme of the present invention has an advantage in terms of the production rate of psychos because the reaction rate is very fast at temperature H (about 50-60 ° C), which is easy to industrially be expected to have an excellent effect on the industrialization of psychos. Example 3 Psychos Production by D-Pycos 3-Epimerase
3-1.고농도과당에서 생물전환에 의한사이코스 생산  3-1.Cycose Production by Bioconversion from High Fructose Fructose
고농도의 사이코스를 생산하기 위하여, 실시예 2—1에서 정제한 D- 사이코스 3-에파머화 효소를 이용하여 상기 실시예 2ᅳ3에서 선정된 최적화 조건 하에서 반웅을 수행하였다. 구체적으로, 실시예 2-1에서 정제한 D- 사이코스 3-에피머화 효소를 0.005 내지 0.1 mg/ml의 농도로 사용하여 50°C 및 50 mM PIPES H 7.5, 및 코발트 1 mM의 조건 하에서 고농도 (500 g/L)의 과당과 반웅시켰다. In order to produce a high concentration of cosmos, reaction was performed under the optimization conditions selected in Example 2-3 using the D- cyclose 3-eparmerase purified in Example 2-1. Specifically, using the D- cyclase 3-epimerase enzyme purified in Example 2-1 at a concentration of 0.005 to 0.1 mg / ml at a high concentration under the conditions of 50 ° C and 50 mM PIPES H 7.5, and cobalt 1 mM It was reacted with (500 g / L) fructose.
상기 실시예 2— 2와 동일한 방법으로 상기 반웅 결과 생산된 사이코스 생산량을 측정하여 과당에서 사이코스로의 전환율을 측정하였다. 사용된 과당이 고농도이기 때문에 각 시간별로 샘플링한 용액을 25배로 희석하여 HPLC 분석 진행하였으며, 분석된 결과 면적 (AREA)값을 각각의 standard값에 대입하여 생산량을 계산 하였으며, 전환율은 생산된 사이코스양 /과당 50%*100으로 계산하였다. 앰플링한 후, 계산하면 분석된 과당과 사이코스의 총량은 50%이다. In the same manner as in Example 2-2, the yield of the produced reaction was measured to determine the conversion rate of fructose to psychocos. As the fructose used was high, HPLC was performed by diluting the sample sampled at each time by 25 times, and the yield was calculated by substituting the analyzed area (AREA) value for each standard value. Calculated as 50% * 100 per amount / fructose. After ampouling, the calculations show the analysis of fructose and The total amount is 50%.
상기 얻어진 결과를 도 7에 나타내었다. 도 7에 나타난 바와 같이, 효소 농도가 높을수록 사이코스 전환를이 증가하는 것으로 나타났다. 예컨대, 효소 농도 0.1 mg/ml에서의 사이코스 최종 생산량이 152 g/L이며, 사이코스 전환률이 약 30.2% 정도이다, 즉, 본 발명의 효소를 사용하여 고농도의 과당쎄서 30% 이상의 전환를로 사이코스를 생산할 수 있다.  The obtained result is shown in FIG. As shown in Figure 7, higher enzyme concentrations were shown to increase the Psychoconversion. For example, the final yield of a psychos at an enzyme concentration of 0.1 mg / ml is 152 g / L, with a psychocos conversion of about 30.2%, i.e. a high concentration of fructose at least 30% using an enzyme of the present invention. Produce a course.
한편, 상기와 같이 고농도 과당에서의 생물 전환에 의한 사이코스 생산성을 HPLC로 측정하여 그 결과를 도 ' 8에 나타내었다. 도 8의 Y축은 굴절률을 나타낸다. 상기 HPLC 분석은 87C(BIO-RAD) 컬럼을 사용하여 80°C에서, 이동상으로 물 100%(v/v)를 0.6 ml/rain 유속으로 흘려 주면서 수행하였고, Refractive Index Detector(Agilent 1260 TID)로 사이코스를 검출하여 사이코스 생산성을 분석하였다. On the other hand, by measuring the psicose production by biological conversion of fructose at high concentrations by HPLC as described above were shown in Fig. "8 the results. The Y axis of FIG. 8 represents a refractive index. The HPLC analysis was performed using a 87C (BIO-RAD) column at 80 ° C, flowing 100% (v / v) of water into the mobile phase at a flow rate of 0.6 ml / rain, using a Refractive Index Detector (Agilent 1260 TID). Psychos were detected and analyzed for psychos productivity.
3-2. 효소가포함된 재조합균주반웅에 의한사이코스생산 3-2. Psycho Production by Recombinant Strain Reaction with Enzyme
상기 실시예 1에서 회수된 재조합 균주의 균체를 이용하여 사이코스를 생산 시험을 하였다. 실시예 2-1의 효소를 사용하는 대신 실시예 1에서 회수된 재조합 균주의 균체를 이용하는 것을 제외하고 상기 3-1과 동일한 방법으로 반웅을 수행하였다. 구체적으로, 50°C, 50 mM PIPES pH 7.5의 조건 하에서 상기 실시예 1의 재조합 균주 10.9, 5.4 또는 2.7 mg (균체건조중량) /mK반웅물 부피)과 500 g/L 과당을 각각 반웅시'켜 상기 실시예 3-1과 동일한 방법으로 사이코스 생산량 및 사이코스 전환율을 측정하였다. Using the cells of the recombinant strain recovered in Example 1 was tested for the production of the cycle. The reaction was carried out in the same manner as in 3-1, except that the cells of the recombinant strain recovered in Example 1 were used instead of the enzyme of Example 2-1. More specifically, 50 ° C, 50 mM PIPES pH 7.5 Example recombinant strain of 1 10.9, 5.4 or 2.7 mg (cell dry weight) under conditions of a / mK banung water by volume) and 500 g / L to when each banung "Fructose On the basis of the same method as in Example 3-1 was measured for the yield of the psychos and the conversion of the psychos.
상기 얻어진 결과를 도 9에 나타내었다. 도 9에서 보여지는 바와 같이, 과당 농도가 500 g/L 및 5.4 mg (균체건조중량) /ml(반웅물 부피)의 조건에서 약 1시간 이후 반웅이 거의 완료되었으며, 이 때 161.9 g/L의 사이코스를 생산하여, 전환율은 약 30.8%를 보였다. 상기 결과로부터 정제된 효소뿐 아니라 재조합 균주 역시 우수한 사이코스 전환 능력을 가짐을 확인할 수 있다. The obtained result is shown in FIG. As shown in FIG. 9, the reaction was almost complete after about 1 hour at a condition of fructose concentration of 500 g / L and 5.4 mg (cell dry weight) / ml (reaction volume), wherein 161.9 g / L With the production of Pycos, the conversion rate was about 30.8%. Only enzyme purified from the above result In addition, it can be confirmed that the recombinant strain also has excellent psychocosylation ability.

Claims

【특허청구범위】 Patent Claim
. 【청구항 1】  . [Claim 1]
서열번호 1의 아미노산 사열을 갖는 D-사이코스 3-에피머화 효소 단백질.  D-psicose 3-epimerase protein having an amino acid sequence of SEQ ID NO: 1.
【청구항 2【Claim 2
제 1항에 있어서, 다음의 특성을 갖는, D-사이코스 3-에피머화 효소 단백질:  The D-cyclic 3-epimerase protein of claim 1 having the following properties:
(a) 분자량: 30 내지 37 kDa;  (a) molecular weight: 30 to 37 kDa;
(b) 최적 활성 온도: 40 내지 65°C; 및 (b) optimum active temperature: 40 to 65 ° C .; And
(c) 최적 활성 pH: pH 6 내지 9. (c) optimum active pH: pH 6-9.
【청구항 3】  [Claim 3]
제 1항의 D-사이코스 3-에피머화 효소 단백질을 암호화 하는 폴리뉴클레오타이드.  A polynucleotide encoding the D-psicose 3-epimerase protein of claim 1.
【청구항 4】. 【Claim 4】 .
제 3항에 있어서, 서열번호 2의 염기 서열을 갖는, 폴리뉴클레오타이드. The polynucleotide of claim 3 having the nucleotide sequence of SEQ ID NO: 2. 5.
【청구항 5】 [Claim 5]
제 1항의 D-사이코스 3-에피머화 효소 단백질올 암호화 하는 폴리뉴클레오타이드를포함하는 재조합 백터. .  A recombinant vector comprising a polynucleotide encoding the D-psicose 3-epimerase protein of claim 1. .
【청구항 6】  [Claim 6]
제 5항에 있어서, 상기 재조합 백터는 도 1의 개열 지도를 갖는 것인, 재조합 백터. ' The recombinant vector of claim 5, wherein the recombinant vector has a cleavage map of FIG. 1. '
【청구항 7】  [Claim 7]
제 5항의 재조합 백터로 형질전환된 재조합 균주.  A recombinant strain transformed with the recombinant vector of claim 5.
【청구항 8】  [Claim 8]
제 7항에 있어서, 상기 재조합 균주는 대장균이 형질전환된 것인, 재조합 균주. According to claim 7, wherein the recombinant strain is E. coli transformed, recombinant strain.
[청구항 9】 [Claim 9]
제 8항에 있어서, Escherichia co//— pETCDPE_SYG321(기탁번호: KCCM11406P)인, 재조합 균주.  The recombinant strain according to claim 8, which is Escherichia co // — pETCDPE_SYG321 (Accession Number: KCCM11406P).
[청구항 10】  [Claim 10]
제 1항 또는 제 2항의 단백질, 제 7항 내지 제 9항 중 어느 한 항의 재조합 균주, 상기 재조합 균주의 배양물 및 상기 재조합 균주의 파쇄물로 이루어진 군에서 선택된 1종 이상을 포함하는,사이코스 제조용 조성물.  Claim 1 or claim 2, wherein the recombinant strain of any one of claims 7 to 9, comprising one or more selected from the group consisting of the culture of the recombinant strain and the lysate of the recombinant strain, for producing a psychos Composition.
[청구항 11】  [Claim 11]
제 10항에 있어서, 망간 이온, 철 이온, 코발트 이온, 또는 이들의 혼합물을 추가로 포함하는. 사이코스 제조용 조성물.  The method of claim 10, further comprising manganese ions, iron ions, cobalt ions, or mixtures thereof. Psychos composition.
[청구항 12】  [Claim 12]
제 10항의 사아코스 제조용 조성물을 과당과 반웅시키는 단계를 포함하는 과당으로부터 사이코스를 생산하는 방법ᅳ  A method for producing a cycos from fructose comprising the step of reacting the composition for preparing sacocos of claim 10 with fructose;
【청구항 13】 [Claim 13]
제 12항에 있어서, 상기 반응은 40 '내지 65°C에서 수행되는 것인, 사이코스를 생산하는 방법. The method of claim 12, wherein the reaction is performed at 40 ' to 65 ° C.
【청구항 14】  [Claim 14]
제 12항에 있어서, 상기 반웅은 pH 6.0 내지 9.0에서 수행되는 것인, 사이코스를 생산하는 방법.  The method of claim 12, wherein the reaction is performed at pH 6.0 to 9.0.
【청구항 15】  [Claim 15]
제 12항에 있어서, 상기 과당의 농도는 40 내지 75%(w/v)인 사이코스를 생산하는 방법.  13. The method of claim 12, wherein said fructose concentration is between 40 and 75% (w / v).
PCT/KR2013/008585 2013-04-09 2013-09-25 D-psicose epimerase, and psicose production method using same WO2014168302A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2013-0038592 2013-04-09
KR20130038592A KR101318422B1 (en) 2013-04-09 2013-04-09 D-psicose epimerase and method for producing psicose using the same

Publications (1)

Publication Number Publication Date
WO2014168302A1 true WO2014168302A1 (en) 2014-10-16

Family

ID=49638528

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2013/008585 WO2014168302A1 (en) 2013-04-09 2013-09-25 D-psicose epimerase, and psicose production method using same

Country Status (2)

Country Link
KR (1) KR101318422B1 (en)
WO (1) WO2014168302A1 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016072800A1 (en) * 2014-11-06 2016-05-12 경상대학교산학협력단 Method for preparing psicose
CN106879991A (en) * 2017-02-19 2017-06-23 沧州恩际生物制品有限公司 A kind of hypoglycemic processing method for jujube class extract solution
US10266862B2 (en) 2014-11-06 2019-04-23 Industry-Academic Cooperation Foundation Gyeongsang National University Method for preparing psicose
US11191292B2 (en) 2016-10-28 2021-12-07 Samyang Corporation Oligosaccharide syrup having improved stability
CN114601745A (en) * 2022-03-25 2022-06-10 上海龙殷生物科技有限公司 Skin care product raw material, cosmetic, preparation method and application
US12024751B2 (en) 2016-12-08 2024-07-02 Samyang Corporation Method for producing psicose

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101539097B1 (en) * 2013-12-26 2015-07-23 주식회사 삼양제넥스 Polynucleotide encoding psicose epimerase and method of producing psicos using the same
KR101473918B1 (en) 2014-05-28 2014-12-17 대상 주식회사 D-psicose 3-epimerase, manufacturing method thereof and manufacturing method of D-psicose using the same
KR101577147B1 (en) * 2014-10-01 2015-12-11 경상대학교산학협력단 Preparing method for psicose
EP3214176B1 (en) 2014-10-30 2020-04-01 Samyang Corporation Expression system of psicose epimerase and production of psicose using same
KR101617379B1 (en) 2015-05-13 2016-05-02 주식회사 삼양사 Mixed sugar granule and method of preparing the same
KR101695831B1 (en) 2015-05-15 2017-01-12 주식회사 삼양사 Saccharide mixture containing psicose with improved sweetness quality and crystallization
KR102087396B1 (en) * 2015-11-16 2020-03-10 주식회사 삼양사 Method of preparing psicose from fructose-containing substrate
KR102069301B1 (en) * 2015-12-21 2020-01-22 주식회사 삼양사 Allose producing-strain using the fructose and method for producing allose using the same
KR20180047894A (en) 2016-11-01 2018-05-10 주식회사 삼양사 Low calorie cereal bar composition
EP3536159B1 (en) 2016-11-01 2024-07-24 Samyang Corporation Chocolate composition having improved processability, and preparation method therefor
KR101874928B1 (en) 2016-11-01 2018-07-05 주식회사 삼양사 Low Calorie Coffee Drink Composition
JP6758499B2 (en) 2016-11-16 2020-09-23 シージェイ チェルジェダン コーポレイション Method for producing D-psicose using microorganisms of the genus Kaistia
CN106520863A (en) * 2016-11-22 2017-03-22 保龄宝生物股份有限公司 Production technology for preparing D-psicose through enzymatic transesferification of D-fructose
KR102072695B1 (en) 2016-12-08 2020-03-02 주식회사 삼양사 Method of preparing psicose with recycling
KR102004941B1 (en) 2016-12-08 2019-07-29 주식회사 삼양사 Method of producing psicose efficiently
KR101988441B1 (en) 2016-12-27 2019-06-12 주식회사 삼양사 Method of purification allulose
KR102004940B1 (en) 2017-06-30 2019-07-29 주식회사 삼양사 production of allulose as sweetener
WO2019083070A1 (en) 2017-10-27 2019-05-02 주식회사 삼양사 Composition for preventing or alleviating nonalcoholic fatty liver disease
US20210177024A1 (en) 2017-10-27 2021-06-17 Samyang Corporation Allulose syrup and method for manufacturing same
KR101965509B1 (en) 2017-11-15 2019-04-03 씨제이제일제당 (주) A Novel D-Psicose 3-Epimerase and Methods for Preparing D-Psicose Using The Same
KR102326587B1 (en) 2018-06-28 2021-11-15 주식회사 삼양사 Low calorie soy milk with reduced soybean odor
WO2020032302A1 (en) 2018-08-10 2020-02-13 주식회사 삼양사 Nutritional drink
CA3145038A1 (en) 2019-07-24 2021-01-28 Kyung Ho Joo Saccharide syrup composition comprising allulose
JP2023500269A (en) * 2019-10-28 2023-01-05 サムヤン コーポレイション Fructose-6-phosphate 3-epimerase and uses thereof
JP7465962B2 (en) 2019-10-31 2024-04-11 サムヤン コーポレイション Improved method for producing allulose
KR102254411B1 (en) 2019-12-19 2021-05-24 대상 주식회사 Variant of D-allulose 3-epimerase, manufacturing method thereof and manufacturing method of D-alluose using the same
KR102448351B1 (en) 2020-04-27 2022-09-28 대상 주식회사 Variant of D-allulose 3-epimerase, manufacturing method thereof and manufacturing method of D-alluose using the same
KR20220096209A (en) 2020-12-30 2022-07-07 주식회사 삼양사 Allulose with improved stability
KR102682846B1 (en) 2021-11-19 2024-07-08 대상 주식회사 Variant of D-allulose 3-epimerase with excellent heat stability, manufacturing method thereof and manufacturing method of D-alluose using the same
JP7534550B2 (en) 2021-12-29 2024-08-14 テサン・コーポレイション Novel promoter variants for constitutive expression and uses thereof
KR102691596B1 (en) 2022-12-20 2024-08-06 대상 주식회사 Novel promoter variant for constitutive expression and use of the same

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060125971A (en) * 2005-06-01 2006-12-07 씨제이 주식회사 D-psicose production method by d-psicose epimerase
KR20110035805A (en) * 2009-09-30 2011-04-06 씨제이제일제당 (주) Method of producing d-psicose using immobilized d-psicose 3-epimerase
KR101203856B1 (en) * 2011-08-24 2012-11-21 씨제이제일제당 (주) D-psicose 3-epimerase variants improved thermostability and continuous production of D-psicose using the variants

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060125971A (en) * 2005-06-01 2006-12-07 씨제이 주식회사 D-psicose production method by d-psicose epimerase
KR20110035805A (en) * 2009-09-30 2011-04-06 씨제이제일제당 (주) Method of producing d-psicose using immobilized d-psicose 3-epimerase
KR101203856B1 (en) * 2011-08-24 2012-11-21 씨제이제일제당 (주) D-psicose 3-epimerase variants improved thermostability and continuous production of D-psicose using the variants

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHOI, JIN-GEUN ET AL.: "Improvement in the Thermostabilhy of D-Psicose 3-Epimerase from Agrobacterium tumefaciens by Random and Site-Directed Mutagenesis.", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, vol. 77, no. 20, October 2011 (2011-10-01), pages 7316 - 7320 *

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016072800A1 (en) * 2014-11-06 2016-05-12 경상대학교산학협력단 Method for preparing psicose
US10266862B2 (en) 2014-11-06 2019-04-23 Industry-Academic Cooperation Foundation Gyeongsang National University Method for preparing psicose
US11191292B2 (en) 2016-10-28 2021-12-07 Samyang Corporation Oligosaccharide syrup having improved stability
US12024751B2 (en) 2016-12-08 2024-07-02 Samyang Corporation Method for producing psicose
CN106879991A (en) * 2017-02-19 2017-06-23 沧州恩际生物制品有限公司 A kind of hypoglycemic processing method for jujube class extract solution
CN106879991B (en) * 2017-02-19 2021-03-26 沧州恩际生物制品有限公司 Blood sugar reducing treatment method for jujube extract
CN114601745A (en) * 2022-03-25 2022-06-10 上海龙殷生物科技有限公司 Skin care product raw material, cosmetic, preparation method and application
CN114601745B (en) * 2022-03-25 2023-06-27 上海龙殷生物科技有限公司 Skin care product raw material, cosmetic, preparation method and application

Also Published As

Publication number Publication date
KR101318422B1 (en) 2013-10-15

Similar Documents

Publication Publication Date Title
KR101318422B1 (en) D-psicose epimerase and method for producing psicose using the same
JP6282746B2 (en) A polynucleotide encoding psicose epimerase and a psicose production method using the same.
KR101539096B1 (en) Composition for converting fructose into psicose, and method for producing psicose using the same
JP6320621B2 (en) Psicose epimerizing enzyme and method for producing psicose using the same
KR101978464B1 (en) D-Fructose-4-epimerase and production of tagatose using the same
KR101610911B1 (en) Production of tagatose from fructose using l-ribulose 5-phosphate 4-epimerase
KR102132381B1 (en) Ketose 3-epimerase produced by arthrobacter globiformis
TWI666323B (en) A d-psicose 3-epimerase, methods for preparing d-psicose using the same, a polynucleotide encoding the same, a recombinant vector, a microorganism and a composition
EP2990483B1 (en) Psicose epimerase mutant and method for preparing psicose by using same
JP2017510302A5 (en)
KR102187354B1 (en) Psicose epimerase and method of psicose using the same
CA3088598C (en) Ketose 3-epimerase with improved thermal stability
KR20140080282A (en) Method for preparing psicose from fructose by using D-psicose 3-epimerase
TWI700370B (en) A composition for producing tagatose and methods for producing tagatose using the same
JP2018537991A (en) Composition for producing D-psicose containing D-psicose 3-epimerase and a salt thereof, and method for producing D-psicose using the same
WO2014025235A1 (en) Psicose epimerase and composition for conversion to psicose using same
KR101965509B1 (en) A Novel D-Psicose 3-Epimerase and Methods for Preparing D-Psicose Using The Same
KR102123012B1 (en) Production for functional sweetener
KR101764840B1 (en) Method for preparing allose by using enzyme producing hyperthermophilic strain
JP7535192B2 (en) Allulose epimerization enzyme mutant with excellent thermostability, its production method, and production method of allulose using the same
KR102141174B1 (en) Expression system for producing amylosucrase and method of producing turanose using the same
WO2022114207A1 (en) Novel l-rhamnose isomerase
CN112867793B (en) Novel fructose-C4-epimerase and method for preparing tagatose using the same
CN118834863A (en) Cellobiose epimerase mutant and application thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13881901

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 13881901

Country of ref document: EP

Kind code of ref document: A1